Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
ATP    O
and    O
undecaprenol    O
,    O
whereas    O
its    O
two    O
products    O
are    O
ADP    O
and    O
undecaprenyl    B-Terpene115068635
phosphate    I-Terpene115068635
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
UDP    O
-    O
galactose    O
and    O
undecaprenyl    B-Terpene115068635
phosphate    I-Terpene115068635
,    O
whereas    O
its    O
two    O
products    O
are    O
UMP    O
and    O
alpha    O
-    O
D    O
-    O
galactosyl    O
-    O
diphosphoundecaprenol    O
.    O

The    O
pronounced    O
flavor    O
and    O
aroma    O
of    O
"    O
shiso    O
"    O
derives    O
from    O
perillaldehyde    B-Terpene115068635
,    O
but    O
this    O
substance    O
is    O
lacking    O
in    O
the    O
"    O
wild    O
sesame    O
"    O
and    O
"    O
sesame    O
leaf    O
"    O
variety    O
.    O

perilla    O
aldehyde    O
-    O
perillaldehyde    B-Terpene115068635
,    O
a    O
flavoring    O

Warfarin    O
and    O
other    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
-    O
inhibiting    O
agents    O
are    O
contraindicated    O
during    O
the    O
first    O
trimester    O
of    O
pregnancy    O
because    O
of    O
the    O
teratogenic    O
effects    O
,    O
and    O
should    O
not    O
be    O
administered    O
when    O
the    O
pregnancy    O
is    O
confirmed    O
.    O

Probiotic    O
treatment    O
has    O
been    O
studied    O
as    O
a    O
means    O
of    O
addressing    O
disorders    O
associated    O
with    O
vitamin    O
deficiencies    O
including    O
those    O
of    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
,    O
folic    O
acid    O
,    O
and    O
vitamin    O
B12    O
.    O

Other    O
diseases    O
linked    O
to    O
internal    O
bleeding    O
include    O
scurvy    O
,    O
hepatoma    O
,    O
liver    O
cancer    O
,    O
Autoimmune    O
Thrombocytopenia    O
,    O
ectopic    O
pregnancy    O
,    O
malignant    O
hypothermia    O
,    O
ovarian    O
cysts    O
,    O
Vitamin    B-Terpene115068635
K    I-Terpene115068635
Deficiency    O
,    O
and    O
hemophilia    O
and    O
malaria    O
.    O

The    O
pathway    O
produces    O
two    O
five    O
-    O
carbon    O
building    O
blocks    O
called    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
IPP    O
)    O
and    O
dimethylallyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
DMAPP    O
)    O
,    O
which    O
are    O
used    O
to    O
make    O
isoprenoids    B-Terpene115068635
,    O
a    O
diverse    O
class    O
of    O
over    O
30,000    O
biomolecules    O
such    O
as    O
cholesterol    O
,    O
heme    O
,    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
,    O
coenzyme    O
Q10    O
,    O
and    O
all    O
steroid    O
hormones    O
.    O

Many    O
multivitamin    O
"    O
formulas    O
"    O
contain    O
vitamin    O
C    O
,    O
B1    O
,    O
B2    O
,    O
B3    O
,    O
B5    O
,    O
B6    O
,    O
B9    O
,    O
B12    O
,    O
biotin    O
,    O
A    O
,    O
E    O
,    O
D2    O
(    O
or    O
D3    O
)    O
,    O
K    B-Terpene115068635
,    O
potassium    O
,    O
iodine    O
,    O
selenium    O
,    O
borate    O
,    O
zinc    O
,    O
calcium    O
,    O
magnesium    O
,    O
manganese    O
,    O
molybdenum    O
,    O
betacarotene    O
,    O
and/or    O
iron    O
.    O

A    O
,    O
D3    O
,    O
E    O
,    O
B6    O
,    O
B12    O
,    O
folic    O
acid    O
(    O
B9    O
)    O
,    O
ascorbic    O
acid    O
(    O
vitamin    O
C    O
)    O
,    O
along    O
with    O
a    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
derivative    O
,    O
menadione    O
sodium    O
bisulfite    O
DVL    O
adds    O
these    O
vitamins    O
to    O
an    O
electrolyte    O
premix    O
that    O
has    O
7    O
mineral    O
salts    O
:    O
magnesium    O
acetate    O
,    O
sodium    O
acetate    O
,    O
calcium    O
acetate    O
,    O
potassium    O
chloride    O
,    O
calcium    O
chloride    O
,    O
sodium    O
chloride    O
and    O
sodium    O
diacetate    O
.    O

Clinical    O
trials    O
have    O
shown    O
promise    O
for    O
these    O
compounds    O
as    O
substitutes    O
for    O
the    O
currently    O
administered    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
antagonists    O
or    O
low    O
molecular    O
weight    O
heparin    O
.    O

Deficiency    O
of    O
vitamin    B-Terpene115068635
K    I-Terpene115068635

Anticoagulant    O
antagonists    O
,    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
and    O
other    O
coagulants    O

Isochorismate    O
synthase    O
(    O
MenF    O
)    O
(    O
EC    O
number    O
5.4.4.2    O
)    O
catalyzes    O
the    O
first    O
step    O
in    O
the    O
biosynthesis    O
of    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
(    O
menaquinone    O
)    O
in    O
"    O
Escherichia    O
coli    O
"    O
.    O

The    O
fat    O
-    O
soluble    O
vitamins    O
A    O
,    O
D    O
,    O
E    O
,    O
and    O
K    B-Terpene115068635
along    O
with    O
essential    O
fatty    O
acids    O
such    O
as    O
linoleic    O
and    O
linolenic    O
acid    O
are    O
found    O
within    O
the    O
milk    O
fat    O
portion    O
of    O
the    O
milk    O
.    O

Vitamin    B-Terpene115068635
K    I-Terpene115068635

At    O
the    O
time    O
,    O
synthetic    O
Vitamin    B-Terpene115068635
K    I-Terpene115068635
was    O
being    O
produced    O
and    O
was    O
often    O
in    O
short    O
supply    O
.    O

When    O
dried    O
(    O
uncooked    O
)    O
,    O
however    O
,    O
100    O
grams    O
of    O
figs    O
supply    O
249    O
calories    O
with    O
the    O
dietary    O
mineral    O
,    O
manganese    O
,    O
in    O
rich    O
content    O
(    O
24%    O
DV    O
)    O
and    O
several    O
other    O
minerals    O
and    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
in    O
moderate    O
amounts    O
of    O
the    O
DV    O
(    O
table    O
)    O
.    O

A    O
typical    O
serving    O
of    O
avocado    O
(    O
100    O
g    O
)    O
is    O
moderate    O
to    O
rich    O
in    O
several    O
B    O
vitamins    O
and    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
,    O
with    O
good    O
content    O
of    O
vitamin    O
C    O
,    O
vitamin    O
E    O
and    O
potassium    O
(    O
right    O
table    O
,    O
USDA    O
nutrient    O
data    O
)    O
.    O

Leaves    O
are    O
particularly    O
rich    O
in    O
vitamin    O
A    O
,    O
vitamin    O
C    O
and    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
,    O
with    O
moderate    O
content    O
of    O
dietary    O
minerals    O
.    O

1,4-Naphthoquinone    O
,    O
of    O
which    O
the    O
Vitamin    B-Terpene115068635
K    I-Terpene115068635
group    O
compounds    O
are    O
derivatives    O

Naphthoquinone    O
forms    O
the    O
central    O
chemical    O
structure    O
of    O
many    O
natural    O
compounds    O
,    O
most    O
notably    O
the    O
K    B-Terpene115068635
vitamins    I-Terpene115068635
.    O

Development    O
of    O
technology    O
for    O
the    O
production    O
of    O
vitamins    O
A1    O
,    O
B1    O
,    O
B2    O
,    O
E    O
,    O
C    O
and    O
K1    B-Terpene115068635
;    O

2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate    O
synthase    O
,    O
also    O
known    O
as    O
SHCHC    O
synthase    O
,    O
is    O
encoded    O
by    O
the    O
menH    O
gene    O
in    O
"    O
E.coli    O
"    O
and    O
functions    O
in    O
the    O
synthesis    O
of    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
The    O
specific    O
step    O
in    O
the    O
synthetic    O
pathway    O
that    O
SHCHC    O
synthase    O
catalyzes    O
is    O
the    O
conversion    O
of    O
5-enolpyruvoyl-6-hydroxy-2-succinylcyclohex-3-ene-1-carboxylate    O
to    O
(    O
1R,6R)-6-hydroxy-2-succinylcyclohexa-2,4-diene-1-carboxylate    O
and    O
pyruvate    O
.    O

Vitamin    B-Terpene115068635
K    I-Terpene115068635
is    O
a    O
fat    O
soluble    O
vitamin    O
known    O
to    O
aid    O
in    O
blood    O
clotting    O
.    O

Specifically    O
,    O
blueberries    O
,    O
as    O
a    O
popular    O
superfood    O
example    O
,    O
are    O
not    O
especially    O
nutrient    O
-    O
dense    O
(    O
considered    O
to    O
be    O
a    O
superfood    O
characteristic    O
)    O
,    O
having    O
moderate    O
content    O
of    O
only    O
three    O
essential    O
nutrients    O
:    O
vitamin    O
C    O
(    O
an    O
antioxidant    O
)    O
,    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
and    O
manganese    O
.    O

They    O
also    O
have    O
higher    O
circulating    O
clotting    O
factors    O
(    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
,    O
prothrombin    O
and    O
platelets    O
)    O
.    O

Additionally    O
,    O
fruits    O
have    O
high    O
concentrations    O
of    O
carotenoids    B-Terpene115068635
,    O
vitamin    O
E    O
and    O
vitamin    B-Terpene115068635
K    I-Terpene115068635

For    O
a    O
prolonged    O
prothrombin    O
time    O
,    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
or    O
fresh    O
frozen    O
plasma    O
may    O
be    O
administered    O
to    O
reduce    O
bleeding    O
risk    O
.    O

It    O
is    O
pharmacologically    O
analogous    O
to    O
warfarin    O
and    O
inhibits    O
the    O
synthesis    O
of    O
Vitamin    B-Terpene115068635
K    I-Terpene115068635
-    O
dependent    O
clotting    O
factors    O
.    O

Vitamin    B-Terpene115068635
K1    I-Terpene115068635
has    O
been    O
suggested    O
,    O
and    O
successfully    O
used    O
,    O
as    O
antidote    O
for    O
pets    O
or    O
humans    O
accidentally    O
or    O
intentionally    O
exposed    O
to    O
anticoagulant    O
poisons    O
.    O

Helen    O
Iglauer    O
Glueck    O
(    O
1907–1995    O
)    O
was    O
an    O
American    O
physician    O
known    O
for    O
her    O
research    O
in    O
blood    O
chemistry    O
that    O
linked    O
bleeding    O
disorders    O
in    O
newborns    O
with    O
lack    O
of    O
Vitamin    B-Terpene115068635
K    I-Terpene115068635
in    O
breast    O
milk    O
.    O

If    O
additional    O
blood    O
tests    O
to    O
check    O
clotting    O
function    O
identify    O
a    O
problem    O
,    O
giving    O
Vitamin    B-Terpene115068635
K    I-Terpene115068635
may    O
help    O
avoid    O
the    O
risk    O
of    O
hemorrhage    O
at    O
delivery    O
.    O

The    O
microbes    O
in    O
the    O
cecum    O
produce    O
vitamin    B-Terpene115068635
K    I-Terpene115068635
,    O
B    O
-    O
complex    O
vitamins    O
,    O
proteins    O
,    O
and    O
fatty    O
acids    O
.    O

PHS    O
serves    O
a    O
similar    O
role    O
to    O
SQS    O
in    O
plants    O
and    O
bacteria    O
,    O
catalyzing    O
the    O
synthesis    O
of    O
phytoene    B-Terpene115068635
,    O
a    O
precursor    O
of    O
carotenoid    B-Terpene115068635
compounds    O
.    O

Phytoene    B-Terpene115068635

geranyl    B-Terpene115068635
acetate    I-Terpene115068635
0.9%    O

Geranyl    B-Terpene115068635
acetate    I-Terpene115068635

eucalyptol    B-Terpene115068635

The    O
rhizome    O
contains    O
an    O
oil    O
,    O
known    O
as    O
galangol    O
,    O
which    O
upon    O
fractional    O
distillation    O
produces    O
cineol    B-Terpene115068635
,    O
which    O
has    O
medicinal    O
properties    O
,    O
pinene    O
and    O
eugenol    B-Terpene115068635
,    O
among    O
others    O
.    O

1,8-cineole    B-Terpene115068635
and    O
camphor    O
are    O
also    O
present    O
in    O
low    O
to    O
moderate    O
qualities    O
.    O

The    O
plant    O
contains    O
an    O
essential    O
oil    O
(    O
0.5%    O
)    O
which    O
consists    O
of    O
monoterpenoids    O
and    O
sesquiterpenoids    O
:    O
α-pinene    O
,    O
β-pinene    O
,    O
1,4-cineol    B-Terpene115068635
,    O
fenchone    B-Terpene115068635
,    O
α-humulene    O
,    O
β-caryophyllene    O
,    O
trans-β-bergamotene    O
.    O

The    O
leaves    O
of    O
this    O
shrub    O
contain    O
monoterpenes    O
including    O
1,8-cineole    B-Terpene115068635
but    O
the    O
amount    O
is    O
low    O
.    O

Camphor    O
,    O
borneol    B-Terpene115068635
and    O
eucalyptol    B-Terpene115068635
are    O
examples    O
of    O
bicyclic    O
monoterpenoids    O
containing    O
ketone    O
,    O
alcohol    O
,    O
and    O
ether    O
functional    O
groups    O
,    O
respectively    O
.    O

Myrtol    O
standardized    O
is    O
a    O
phytotherapeutic    O
extract    O
(    O
distillate    O
)    O
consisting    O
mainly    O
of    O
three    O
monoterpenes    O
:    O
(    O
+    O
)    O
-α-pinene    O
,    O
d    O
-    O
limonene    O
and    O
1,8-cineole    B-Terpene115068635
(    O
as    O
known    O
as    O
"    O
Eucalyptol    O
"    O
,    O
but    O
not    O
be    O
confused    O
with    O
Eucalyptus    O
oil    O
)    O
.    O

Sagebrush    O
essential    O
oil    O
contains    O
approximately    O
40%    O
"    O
l    O
"-    O
camphor    O
;    O
20%    O
pinene    O
;    O
7%    O
cineole    B-Terpene115068635
;    O
5%    O
methacrolein    O
;    O
and    O
12%    O
"    O
a    O
"-    O
terpinene    O
,    O
"    O
d    O
"-    O
camphor    O
,    O
and    O
sesqiterpenoids    O
.    O

While    O
largely    O
indistinguishable    O
in    O
appearance    O
,    O
specimens    O
of    O
"    O
T.    O
vulgaris    O
"    O
may    O
be    O
assigned    O
to    O
one    O
of    O
seven    O
different    O
chemotypes    O
,    O
depending    O
on    O
whether    O
the    O
dominant    O
component    O
of    O
the    O
essential    O
oil    O
is    O
thymol    O
,    O
carvacrol    B-Terpene115068635
,    O
linalool    O
,    O
geraniol    B-Terpene115068635
,    O
sabinene    O
hydrate    O
(    O
thuyanol    O
)    O
,    O
α-terpineol    B-Terpene115068635
,    O
or    O
eucalyptol    B-Terpene115068635
.    O

Single    O
synthetic    O
compounds    O
are    O
commonly    O
used    O
as    O
bait    O
to    O
attract    O
and    O
collect    O
males    O
for    O
study    O
,    O
and    O
include    O
many    O
familiar    O
flavorings    O
and    O
odors    O
considered    O
appealing    O
to    O
humans    O
(    O
e.g.    O
,    O
methyl    O
salicylate    O
,    O
eugenol    B-Terpene115068635
,    O
cineole    B-Terpene115068635
,    O
benzyl    O
acetate    O
,    O
methyl    O
benzoate    O
,    O
methyl    O
cinnamate    O
)    O
,    O
and    O
others    O
which    O
are    O
not    O
(    O
e.g.    O
,    O
skatole    O
)    O
.    O

Major    O
constituents    O
reported    O
as    O
:    O
ascaridole    O
(    O
16    O
-    O
38%    O
)    O
,    O
1,8-cineole    B-Terpene115068635
(    O
11    O
-    O
39%    O
)    O
and    O
p    O
-    O
Cymene    O
(    O
9    O
-    O
29%    O
)    O
.    O

The    O
dried    O
cubeb    O
berries    O
contain    O
essential    O
oil    O
consisting    O
monoterpenes    O
(    O
sabinene    O
50%    O
,    O
α-thujene    O
,    O
and    O
carene    O
)    O
and    O
sesquiterpenes    O
(    O
caryophyllene    O
,    O
copaene    O
,    O
α-    O
and    O
β-cubebene    O
,    O
δ-cadinene    O
,    O
germacrene    O
)    O
,    O
the    O
oxides    O
1,4-    O
and    O
cineole    B-Terpene115068635
and    O
the    O
alcohol    O
cubebol    O
.    O

Retinoid    B-Terpene115068635
(    O
e.g.    O
,    O
isotretinoin    O
)    O

Additional    O
treatments    O
include    O
retinoid    B-Terpene115068635
,    O
such    O
as    O
acitretin    O
,    O
or    O
sulfasalazine    O
.    O

Common    O
treatments    O
include    O
simple    O
sunlight    O
,    O
ultraviolet    O
light    O
(    O
mainly    O
NB    O
-    O
UVB    O
312    O
nm    O
)    O
,    O
topical    O
steroids    O
,    O
topical    O
and    O
systemic    O
chemotherapies    O
,    O
local    O
superficial    O
radiotherapy    O
,    O
the    O
histone    O
deacetylase    O
inhibitor    O
vorinostat    O
,    O
total    O
skin    O
electron    O
beam    O
radiation    O
,    O
photopheresis    O
and    O
systemic    O
therapies    O
(    O
e.g.    O
interferons    O
,    O
retinoid    B-Terpene115068635
,    O
rexinoids    O
)    O
or    O
biological    O
therapies    O
.    O

Adarotene    O
is    O
a    O
bioactive    O
retinoid    B-Terpene115068635
.    O

Retinoic    O
acid    O
is    O
a    O
retinoid    B-Terpene115068635
.    O

UV    O
irradiation    O
can    O
be    O
utilized    O
after    O
curetting    O
the    O
hyperkeratosis    O
with    O
a    O
combination    O
medication    O
treatment    O
of    O
oral    O
retinoid    B-Terpene115068635
,    O
psoralen    O
and    O
Ultraviolet    O
A    O
radiation    O
.    O

Topical    O
corticosteroid    O
preparations    O
are    O
the    O
most    O
effective    O
agents    O
when    O
used    O
continuously    O
for    O
8    O
weeks    O
;    O
retinoid    B-Terpene115068635
and    O
coal    O
tar    O
were    O
found    O
to    O
be    O
of    O
limited    O
benefit    O
and    O
may    O
be    O
no    O
better    O
than    O
placebo    O
.    O

Ointment    O
and    O
creams    O
containing    O
coal    O
tar    O
,    O
dithranol    O
,    O
corticosteroids    O
(    O
i.e.    O
desoximetasone    O
)    O
,    O
fluocinonide    O
,    O
vitamin    O
D3    O
analogs    O
(    O
for    O
example    O
,    O
calcipotriol    O
)    O
,    O
and    O
retinoid    B-Terpene115068635
are    O
routinely    O
used    O
.    O

Non    O
-    O
biologic    O
systemic    O
treatments    O
frequently    O
used    O
for    O
psoriasis    O
include    O
methotrexate    O
,    O
ciclosporin    O
,    O
hydroxycarbamide    O
,    O
fumarates    O
such    O
as    O
dimethyl    O
fumarate    O
,    O
and    O
retinoids    B-Terpene115068635
.    O

Topical    O
creams    O
and    O
lotions    O
are    O
currently    O
the    O
most    O
commonly    O
used    O
treatment    O
for    O
keratosis    O
pilaris    O
,    O
specifically    O
those    O
consisting    O
of    O
moisturizing    O
or    O
keratolytic    O
treatments    O
,    O
including    O
urea    O
,    O
lactic    O
acid    O
,    O
glycolic    O
acid    O
,    O
salicylic    O
acid    O
,    O
vitamin    O
D    O
,    O
or    O
topical    O
retinoids    B-Terpene115068635
such    O
as    O
tretinoin    O
.    O

Involved    O
in    O
retinoid    B-Terpene115068635
metabolism    O
.    O

Abietane    O
is    O
a    O
diterpene    O
that    O
forms    O
the    O
structural    O
basis    O
for    O
a    O
variety    O
of    O
natural    O
chemical    O
compounds    O
such    O
as    O
abietic    B-Terpene115068635
acid    I-Terpene115068635
,    O
carnosic    B-Terpene115068635
acid    I-Terpene115068635
,    O
and    O
ferruginol    B-Terpene115068635
which    O
are    O
collectively    O
known    O
as    O
abietanes    O
or    O
abietane    O
diterpenes    O
.    O

Pseudomonas    O
vancouverensis    O
is    O
a    O
Gram    O
-    O
negative    O
soil    O
bacterium    O
that    O
grows    O
on    O
pulp    O
mill    O
effluents    O
with    O
resin    B-Terpene115068635
acid    I-Terpene115068635
.    O

Resin    B-Terpene115068635
acid    I-Terpene115068635
refers    O
to    O
mixtures    O
of    O
several    O
related    O
carboxylic    O
acids    O
,    O
primarily    O
abietic    B-Terpene115068635
acid    I-Terpene115068635
,    O
found    O
in    O
tree    O
resins    O
.    O

Recent    O
studies    O
have    O
found    O
that    O
great    O
mullein    O
contains    O
glycyrrhizin    B-Terpene115068635
compounds    O
with    O
bactericide    O
and    O
potential    O
anti    O
-    O
tumoral    O
action    O
.    O

This    O
deficiency    O
—    O
known    O
as    O
apparent    O
mineralocorticoid    O
excess    O
syndrome    O
—    O
can    O
either    O
be    O
congenital    O
or    O
caused    O
by    O
consumption    O
of    O
glycyrrhizin    B-Terpene115068635
,    O
which    O
is    O
contained    O
in    O
extract    O
of    O
licorice    O
,    O
sometimes    O
found    O
in    O
herbal    O
supplements    O
,    O
candies    O
,    O
and    O
chewing    O
tobacco    O
.    O

Glycyrrhizin    B-Terpene115068635

Together    O
these    O
plants    O
are    O
used    O
to    O
create    O
a    O
drink    O
containing    O
puerarin    O
,    O
daidzein    O
,    O
paenoflorin    O
,    O
cinnamic    O
acid    O
,    O
glycyrrhizin    B-Terpene115068635
,    O
ephedrine    O
and    O
gingerol    O
.    O

It    O
contains    O
the    O
chemical    O
glycyrrhizin    B-Terpene115068635
,    O
which    O
has    O
medicinal    O
uses    O
,    O
but    O
at    O
higher    O
levels    O
it    O
can    O
be    O
toxic    O
.    O

Valerenic    B-Terpene115068635
Acid    I-Terpene115068635
(    O
partial    O
agonist    O
)    O

The    O
binding    O
site    O
of    O
loreclezole    O
has    O
been    O
shown    O
experimentally    O
to    O
be    O
shared    O
by    O
valerenic    B-Terpene115068635
acid    I-Terpene115068635
,    O
an    O
extract    O
of    O
the    O
root    O
of    O
the    O
valerian    O
plant    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl    O
-    O
CoA    O
and    O
10-deacetylbaccatin    B-Terpene115068635
III    I-Terpene115068635
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
baccatin    O
III    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
benzoyl    O
-    O
CoA    O
and    O
10-deacetyl-2-debenzoylbaccatin    O
III    O
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
10-deacetylbaccatin    B-Terpene115068635
III    I-Terpene115068635
.    O

Jasmone    B-Terpene115068635
is    O
an    O
organic    O
compound    O
,    O
which    O
is    O
a    O
volatile    O
portion    O
of    O
the    O
oil    O
from    O
jasmine    O
flowers    O
.    O

Bacteriohopanepolyol    B-Terpene115068635

Limonoid    B-Terpene115068635
such    O
as    O
limonin    B-Terpene115068635
,    O
nomilin    O
,    O
and    O
nomilinic    O
acid    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
limonoate    B-Terpene115068635
D-ring-lactone    I-Terpene115068635
and    O
H2O    O
,    O
whereas    O
its    O
product    O
is    O
limonoate    O
.    O

Camphine    B-Terpene115068635
was    O
the    O
trade    O
name    O
of    O
a    O
purified    O
spirit    O
of    O
turpentine    O
formerly    O
used    O
for    O
lamps    O
,    O
generally    O
prepared    O
by    O
distilling    O
turpentine    O
with    O
quicklime    O
.    O

A    O
chemical    O
compound    O
isolated    O
from    O
the    O
plant    O
,    O
callicarpenal    B-Terpene115068635
,    O
was    O
effective    O
as    O
a    O
mosquito    O
repellent    O
in    O
a    O
laboratory    O
experiment    O
using    O
a    O
simulated    O
skin    O
model    O
.    O

enoxolone    B-Terpene115068635
(    O
INN    O
)    O

Licorice    O
,    O
which    O
contains    O
glycyrrhetinic    B-Terpene115068635
acid    I-Terpene115068635
,    O
or    O
enoxolone    B-Terpene115068635
can    O
inhibit    O
11β-HSD    O
and    O
lead    O
to    O
a    O
mineralocorticoid    O
excess    O
syndrome    O
.    O

Once    O
detached    O
from    O
the    O
porphyrin    O
ring    O
,    O
this    O
long    O
hydrocarbon    O
tail    O
becomes    O
the    O
precursor    O
of    O
two    O
biomarkers    O
,    O
pristane    B-Terpene115068635
and    O
phytane    O
.    O

The    O
name    O
of    O
the    O
substance    O
is    O
derived    O
from    O
pristane    B-Terpene115068635
(    O
2,6,10,14-tetramethylpentadecane    O
)    O
,    O
the    O
corresponding    O
hydrocarbon    O
.    O

The    O
chemical    O
structure    O
of    O
rubber    O
from    O
the    O
mushroom    O
consists    O
of    O
a    O
high    O
molecular    O
mass    O
homologue    O
of    O
polyprenol    B-Terpene115068635
,    O
arranged    O
as    O
a    O
dimethylallyl    O
group    O
,    O
two    O
"    O
trans    O
"    O
isoprene    O
units    O
,    O
a    O
long    O
sequence    O
of    O
"    O
cis    O
"    O
isoprenes    O
(    O
between    O
260–300    O
units    O
)    O
,    O
terminated    O
by    O
a    O
hydroxyl    O
or    O
fatty    O
acid    O
ester    O
.    O

The    O
enzyme    O
is    O
involved    O
in    O
biosynthesis    O
of    O
dolichol    B-Terpene115068635
(    O
a    O
long    O
-    O
chain    O
polyprenol    B-Terpene115068635
)    O
with    O
a    O
saturated    O
alpha    O
-    O
isoprene    O
unit    O
.    O

Some    O
commercially    O
significant    O
enones    O
are    O
produced    O
by    O
condensations    O
of    O
acetone    O
,    O
e.g.    O
mesityl    O
oxide    O
and    O
isophorone    B-Terpene115068635
.    O

In    O
the    O
original    O
paper    O
describing    O
this    O
reaction    O
,    O
methylmagnesium    O
bromide    O
is    O
reacted    O
with    O
isophorone    B-Terpene115068635
with    O
and    O
without    O
1    O
mole    O
percent    O
of    O
added    O
copper(I    O
)    O
chloride    O
(    O
see    O
figure    O
)    O
.    O

Resin    B-Terpene115068635
acid    I-Terpene115068635
refers    O
to    O
mixtures    O
of    O
several    O
related    O
carboxylic    O
acids    O
,    O
primarily    O
abietic    B-Terpene115068635
acid    I-Terpene115068635
,    O
found    O
in    O
tree    O
resins    O
.    O

abietic    B-Terpene115068635
acid    I-Terpene115068635

Kraft    O
soap    O
can    O
be    O
reneutralized    O
with    O
sulfuric    O
acid    O
to    O
restore    O
the    O
acidic    O
forms    O
abietic    B-Terpene115068635
acid    I-Terpene115068635
,    O
palmitic    O
acid    O
,    O
and    O
related    O
resin    O
acid    O
components    O
.    O

Fusicoccin    B-Terpene115068635

Geraniol    B-Terpene115068635

Isomeric    O
with    O
nerol    O
is    O
geraniol    B-Terpene115068635
,    O
wherein    O
the    O
double    O
bond    O
is    O
trans    O
.    O

Geraniol    B-Terpene115068635

Hydrolysis    O
of    O
the    O
phosphate    O
groups    O
leads    O
to    O
the    O
prototypical    O
acyclic    O
monoterpenoid    O
geraniol    B-Terpene115068635
.    O

Several    O
floral    O
scent    O
compounds    O
of    O
"    O
Monotropastrum    O
humile    O
"    O
,    O
linalool    O
,    O
α-terpineol    B-Terpene115068635
,    O
and    O
geraniol    B-Terpene115068635
,    O
have    O
been    O
demonstrated    O
to    O
be    O
bumble    O
bee    O
attractants    O
.    O

Examples    O
of    O
monoterpenes    O
and    O
monoterpenoids    O
include    O
geraniol    B-Terpene115068635
,    O
terpineol    B-Terpene115068635
(    O
present    O
in    O
lilacs    O
)    O
,    O
limonene    O
(    O
present    O
in    O
citrus    O
fruits    O
)    O
,    O
myrcene    O
(    O
present    O
in    O
hops    O
)    O
,    O
linalool    O
(    O
present    O
in    O
lavender    O
)    O
or    O
pinene    O
(    O
present    O
in    O
pine    O
trees    O
)    O
.    O

While    O
largely    O
indistinguishable    O
in    O
appearance    O
,    O
specimens    O
of    O
"    O
T.    O
vulgaris    O
"    O
may    O
be    O
assigned    O
to    O
one    O
of    O
seven    O
different    O
chemotypes    O
,    O
depending    O
on    O
whether    O
the    O
dominant    O
component    O
of    O
the    O
essential    O
oil    O
is    O
thymol    O
,    O
carvacrol    B-Terpene115068635
,    O
linalool    O
,    O
geraniol    B-Terpene115068635
,    O
sabinene    O
hydrate    O
(    O
thuyanol    O
)    O
,    O
α-terpineol    B-Terpene115068635
,    O
or    O
eucalyptol    B-Terpene115068635
.    O

Some    O
geranyl    B-Terpene115068635
can    O
be    O
found    O
in    O
"    O
P.    O
tomentosa    O
"    O
.    O

He    O
worked    O
with    O
Philippe    O
Barbier    O
on    O
terpene    O
derivatives    O
used    O
in    O
the    O
manufacture    O
of    O
perfumes    O
like    O
citral    B-Terpene115068635
,    O
rhodinal    O
and    O
geraniol    B-Terpene115068635
.    O

A    O
second    O
-    O
line    O
chemotherapy    O
treatment    O
is    O
cabazitaxel    B-Terpene115068635
.    O

Probably    O
the    O
most    O
important    O
chemical    O
compound    O
within    O
hops    O
are    O
the    O
alpha    O
acids    O
or    O
humulones.    B-Terpene115068635

Humulone    B-Terpene115068635
(    O
α-lupulic    B-Terpene115068635
acid    I-Terpene115068635
)    O
,    O
a    O
vinylogous    O
type    O
of    O
organic    O
acid    O
,    O
is    O
a    O
bitter    O
-    O
tasting    O
chemical    O
compound    O
found    O
in    O
the    O
resin    O
of    O
mature    O
hops    O
(    O
"    O
Humulus    O
lupulus    O
"    O
)    O
.    O

Luteone    B-Terpene115068635
(terpenoid)    I-Terpene115068635
,    O
a    O
twenty    O
-    O
three    O
carbon    O
terpenoid    O
from    O
the    O
dorid    O
nudibranch    O
"    O
Cadlina    O
luteomarginata    O
"    O

Citronellol    B-Terpene115068635

Additional    O
rearrangements    O
and    O
oxidations    O
provide    O
compounds    O
such    O
as    O
citral    B-Terpene115068635
,    O
citronellal    O
,    O
citronellol    B-Terpene115068635
,    O
linalool    O
,    O
and    O
many    O
others    O
.    O

The    O
compound    O
responsible    O
for    O
the    O
characteristic    O
aroma    O
was    O
identified    O
as    O
(    O
–)-("S")-citronellal    O
,    O
which    O
is    O
contained    O
in    O
the    O
leaf    O
oil    O
up    O
to    O
80%    O
;    O
minor    O
components    O
include    O
citronellol    B-Terpene115068635
(    O
10%    O
)    O
,    O
nerol    B-Terpene115068635
and    O
limonene    O
.    O

Ascofuranone    B-Terpene115068635
is    O
an    O
antibiotic    O
produced    O
by    O
various    O
ascomycete    O
fungi    O
including    O
"    O
Acremonium    O
sclerotigenum    O
"    O
that    O
inhibits    O
the    O
"    O
Trypanosoma    O
brucei    O
"    O
alternative    O
oxidase    O
and    O
is    O
a    O
lead    O
compound    O
in    O
efforts    O
to    O
produce    O
other    O
drugs    O
targeting    O
this    O
enzyme    O
for    O
the    O
treatment    O
of    O
sleeping    O
sickness    O
.    O

Additionally    O
,    O
other    O
wild    O
species    O
have    O
bitter    O
fruit    O
containing    O
cucurbitacin    B-Terpene115068635
.    O

Important    O
sub    O
-    O
classes    O
include    O
sterols    O
and    O
cucurbitacin    B-Terpene115068635
.    O

The    O
fruit    O
and    O
foliage    O
are    O
toxic    O
due    O
to    O
the    O
presence    O
of    O
cucurbitacin    B-Terpene115068635
.    O

This    O
plant    O
,    O
and    O
especially    O
its    O
fruit    O
,    O
is    O
poisonous    O
,    O
containing    O
cucurbitacin    B-Terpene115068635
.    O

Cucurbitacin    B-Terpene115068635

:    O
geranylgeranyl    B-Terpene115068635
diphosphate    I-Terpene115068635
+    O
isopentenyl    B-Terpene115068635
diphosphate    I-Terpene115068635
(    O
geranylfarnesyl    B-Terpene115068635
diphosphate    I-Terpene115068635
+    O
diphosphate    O

Among    O
the    O
many    O
irritant    O
and    O
toxic    O
chemicals    O
found    O
in    O
these    O
secretions    O
are    O
alkaloids    O
,    O
benzoquinones    O
,    O
phenols    O
,    O
terpenoid    B-Terpene115068635
,    O
and    O
hydrogen    O
cyanide    O
.    O

isoprenoid    B-Terpene115068635
:    O
-270    O
±    O
75‰    O
(    O
142    O
-    O
376‰    O
more    O
D    O
-    O
depleted    O
than    O
growth    O
water    O
)    O

an    O
Iresin    O
Diester    O
and    O
a    O
terpenoid    B-Terpene115068635
,    O

The    O
apicoplast    O
is    O
also    O
thought    O
to    O
have    O
a    O
role    O
in    O
isoprenoid    B-Terpene115068635
synthesis    O
,    O
which    O
are    O
prosthetic    O
groups    O
on    O
many    O
enzymes    O
and    O
also    O
act    O
as    O
precursors    O
to    O
ubiquinones    O
(    O
involved    O
in    O
electron    O
transport    O
)    O
and    O
dolichol    B-Terpene115068635
(    O
involved    O
in    O
glycoprotein    O
formation    O
)    O
.    O

Mevalonate    O
kinase    O
deficiency    O
,    O
also    O
called    O
mevalonic    O
aciduria    O
and    O
hyper    O
immunoglobin    O
D    O
syndrome    O
is    O
an    O
autosomal    O
recessive    O
metabolic    O
disorder    O
that    O
disrupts    O
the    O
biosynthesis    O
of    O
cholesterol    O
and    O
isoprenoid    B-Terpene115068635
.    O

Botryococcenes    O
are    O
unbranched    O
isoprenoid    B-Terpene115068635
triterpenes    B-Terpene115068635
having    O
the    O
formula    O
C"n"H2"n"-10    O
.    O

This    O
enzyme    O
participates    O
in    O
diterpenoid    B-Terpene115068635
biosynthesis    I-Terpene115068635
.    O

This    O
enzyme    O
participates    O
in    O
diterpenoid    B-Terpene115068635
biosynthesis    I-Terpene115068635
.    O

It    O
is    O
the    O
second    O
reaction    O
in    O
the    O
mevalonate    O
-    O
dependent    O
isoprenoid    B-Terpene115068635
biosynthesis    O
pathway    O
.    O

This    O
enzyme    O
participates    O
in    O
diterpenoid    B-Terpene115068635
biosynthesis    I-Terpene115068635
.    O

In    O
enzymology    O
,    O
a    O
chrysanthemyl    O
diphosphate    O
synthase    O
is    O
an    O
enzyme    O
involved    O
in    O
the    O
biosynthesis    O
of    O
terpenoid    B-Terpene115068635
.    O

This    O
enzyme    O
participates    O
in    O
terpenoid    B-Terpene115068635
biosynthesis    I-Terpene115068635
.    O

This    O
enzyme    O
participates    O
in    O
biosynthesis    O
of    O
steroids    O
and    O
terpenoid    B-Terpene115068635
biosynthesis    I-Terpene115068635
.    O

Geranyltranstransferases    O
are    O
an    O
evolutionarily    O
conserved    O
class    O
of    O
enzymes    O
in    O
Archaea    O
,    O
Bacteria    O
,    O
and    O
Eukarya    O
that    O
participate    O
in    O
a    O
broad    O
range    O
of    O
biosynthetic    O
pathways    O
including    O
those    O
of    O
cholesterol    O
,    O
porphyrin    O
,    O
carotenoids    B-Terpene115068635
,    O
ubiquinone    O
,    O
and    O
isoprenoids    B-Terpene115068635
.    O

This    O
enzyme    O
participates    O
in    O
terpenoid    B-Terpene115068635
biosynthesis    I-Terpene115068635
.    O

Delta    O
-    O
cadinene    O
synthase    O
,    O
a    O
sesquiterpene    O
cyclase    O
,    O
is    O
an    O
enzyme    O
expressed    O
in    O
plants    O
that    O
catalyzes    O
a    O
cyclization    O
reaction    O
in    O
terpenoid    B-Terpene115068635
biosynthesis    O
.    O

In    O
terms    O
of    O
structure    O
,    O
humulone    O
is    O
a    O
phloroglucinol    O
derivative    O
with    O
three    O
isoprenoid    B-Terpene115068635
side    O
-    O
chains    O
.    O

Big    O
Sagebrush    O
has    O
a    O
strong    O
pungent    O
fragrance    O
(    O
especially    O
when    O
wet    O
)    O
due    O
to    O
the    O
presence    O
of    O
camphor    O
,    O
terpenoids    B-Terpene115068635
and    O
other    O
volatile    O
oils    O
.    O

Chemically    O
,    O
the    O
active    O
medicinal    O
constituents    O
include    O
camphor    O
,    O
terpenoids    B-Terpene115068635
,    O
and    O
tannins    O
.    O

Capsidiol    O
is    O
a    O
terpenoid    B-Terpene115068635
compound    O
that    O
accumulates    O
in    O
tobacco    O
"    O
Nicotiana    O
tabacum    O
"    O
and    O
chili    O
pepper    O
"    O
Capsicum    O
annuum    O
"    O
in    O
response    O
to    O
fungal    O
infection    O
.    O

Illustration    O
of    O
the    O
isoprenoid    B-Terpene115068635
components    O
involved    O
in    O
the    O
biosynthesis    O
of    O
Absinthin    O
.    O

Geranyl    O
pyrophosphate    O
is    O
a    O
major    O
branch    O
point    O
for    O
terpenoid    B-Terpene115068635
synthesis    O
.    O

The    O
terpenoids    B-Terpene115068635
,    O
sometimes    O
called    O
isoprenoids    B-Terpene115068635
,    O
are    O
a    O
large    O
and    O
diverse    O
class    O
of    O
naturally    O
occurring    O
organic    O
chemicals    O
similar    O
to    O
terpenes    O
,    O
derived    O
from    O
five    O
-    O
carbon    O
isoprene    O
units    O
assembled    O
and    O
modified    O
in    O
thousands    O
of    O
ways    O
.    O

The    O
difference    O
between    O
terpenes    O
and    O
terpenoid    B-Terpene115068635
is    O
that    O
terpenes    O
are    O
hydrocarbons    O
,    O
whereas    O
terpenoids    O
contain    O
additional    O
functional    O
groups    O
.    O

When    O
terpenes    O
are    O
modified    O
chemically    O
,    O
such    O
as    O
by    O
oxidation    O
or    O
rearrangement    O
of    O
the    O
carbon    O
skeleton    O
,    O
the    O
resulting    O
compounds    O
are    O
generally    O
referred    O
to    O
as    O
terpenoid    B-Terpene115068635
.    O

Terpenoids    O
are    O
also    O
known    O
as    O
isoprenoid    B-Terpene115068635
.    O

It    O
specifically    O
inhibits    O
DXP    O
reductoisomerase    O
,    O
a    O
key    O
enzyme    O
in    O
the    O
non    O
-    O
mevalonate    O
pathway    O
of    O
isoprenoid    B-Terpene115068635
biosynthesis    O
.    O

Terpenoid    B-Terpene115068635
,    O
produced    O
by    O
conifers    O
and    O
angiosperms    O
,    O
consist    O
of    O
ring    O
structures    O
formed    O
of    O
isoprene    O
(    O
C5H8    O
)    O
units    O
.    O

Phytochemicals    O
are    O
the    O
active    O
biological    O
component    O
of    O
plants    O
and    O
some    O
phytochemicals    O
including    O
tannins    O
,    O
alkaloids    O
,    O
terpenoid    B-Terpene115068635
and    O
flavonoids    O
possess    O
antimicrobial    O
activity    O
.    O

The    O
biosynthesis    O
of    O
CBG    O
begins    O
by    O
loading    O
hexanoyl    O
-    O
CoA    O
onto    O
a    O
polyketide    O
synthase    O
assembly    O
protein    O
and    O
subsequent    O
condensation    O
with    O
three    O
molecules    O
of    O
malonyl    O
-    O
CoA.    O
This    O
polyketide    O
is    O
cyclized    O
to    O
olivetolic    O
acid    O
via    O
olivetolic    O
acid    O
cyclase    O
,    O
and    O
then    O
prenylated    O
with    O
a    O
ten    O
carbon    O
isoprenoid    B-Terpene115068635
precursor    O
,    O
geranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
GPP    O
)    O
,    O
using    O
an    O
aromatic    O
prenyltransferase    O
enzyme    O
,    O
geranyl    O
-    O
pyrophosphate—    O

This    O
isomerization    O
is    O
a    O
key    O
step    O
in    O
the    O
biosynthesis    O
of    O
isoprenoids    B-Terpene115068635
through    O
the    O
mevalonate    O
pathway    O
.    O

As    O
do    O
other    O
blister    O
beetles    O
,    O
these    O
produce    O
cantharidin    O
,    O
a    O
toxic    O
terpenoid    B-Terpene115068635
which    O
can    O
kill    O
animals    O
such    O
as    O
horses    O
if    O
they    O
ingest    O
enough    O
of    O
the    O
beetles    O
.    O

Cholesterol    O
is    O
bio    O
-    O
synthesised    O
from    O
mevalonate    O
via    O
a    O
squalene    O
cyclisation    O
of    O
terpenoids    B-Terpene115068635
.    O

The    O
aroma    O
of    O
pepper    O
is    O
attributed    O
to    O
rotundone    B-Terpene115068635
(    O
3,4,5,6,7,8-Hexahydro-3α,8α-dimethyl-5α-(1-methylethenyl)azulene-1(2H)-one    O
)    O
,    O
a    O
sesquiterpene    O
originally    O
discovered    O
in    O
the    O
tubers    O
of    O
cyperus    O
rotundus    O
,    O
which    O
can    O
be    O
detected    O
in    O
concentrations    O
of    O
0.4    O
nanograms    O
/    O
L    O
in    O
water    O
and    O
in    O
wine    O
:    O
rotundone    O
is    O
also    O
present    O
in    O
marjoram    O
,    O
oregano    O
,    O
rosemary    O
,    O
basil    O
,    O
thyme    O
,    O
and    O
geranium    O
,    O
as    O
well    O
as    O
in    O
some    O
Shiraz    O
wines    O
.    O

The    O
oil    O
exact    O
composition    O
is    O
:    O
α-pinene    O
(    O
20.2%    O
)    O
,    O
sabinene    O
(    O
12.0%    O
)    O
,    O
p    O
-    O
cymene    O
(    O
7.0%    O
)    O
and    O
terpinen-4-ol    B-Terpene115068635
(    O
29.6%    O
)    O
.    O

Of    O
these    O
linalool    O
and    O
linalyl    B-Terpene115068635
acetate    I-Terpene115068635
dominate    O
,    O
with    O
moderate    O
levels    O
of    O
lavandulyl    O
acetate    O
,    O
terpinen-4-ol    B-Terpene115068635
and    O
lavandulol    O
.    O

Hence    O
,    O
this    O
enzyme    O
has    O
one    O
substrate    O
,    O
dimethylallyl    B-Terpene115068635
diphosphate    I-Terpene115068635
,    O
and    O
two    O
products    O
,    O
diphosphate    O
and    O
lavandulyl    O
diphosphate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
dimethylallyl    B-Terpene115068635
diphosphate    I-Terpene115068635
and    O
(    O
-)-(2S)-naringenin    O
,    O
whereas    O
its    O
two    O
products    O
are    O
diphosphate    O
and    O
sophoraflavanone    O
B.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
dimethylallyl    B-Terpene115068635
diphosphate    I-Terpene115068635
and    O
L    O
-    O
tryptophan    O
,    O
whereas    O
its    O
two    O
products    O
are    O
diphosphate    O
and    O
4-(3-methylbut-2-enyl)-L    O
-    O
tryptophan    O
.    O

The    O
biosynthesis    O
of    O
α-terpinene    O
and    O
other    O
terpenoids    O
occurs    O
via    O
the    O
mevalonate    O
pathway    O
because    O
its    O
starting    O
reactant    O
,    O
dimethylallyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
DMAPP    O
)    O
,    O
is    O
derived    O
from    O
mevalonic    O
acid    O
.    O

Dimethylallyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
is    O
then    O
obtained    O
from    O
the    O
deoxyxylulose    O
pathway    O
,    O
where    O
prenylation    O
of    O
the    O
benzenoid    O
occurs    O
,    O
yielding    O
humulone    O
.    O

IPP    O
is    O
isomerized    O
to    O
the    O
allylic    O
ester    O
dimethylallyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
DMAPP    O
)    O
by    O
IPP    O
isomerase    O
.    O

Finally    O
,    O
MEcPP    O
is    O
converted    O
to    O
(    O
"    O
E")-4-hydroxy-3-methyl    O
-    O
but-2-enyl    O
pyrophosphate    O
(    O
HMB    O
-    O
PP    O
)    O
by    O
HMB    O
-    O
PP    O
synthase    O
(    O
GcpE    O
,    O
IspG    O
)    O
,    O
and    O
HMB    O
-    O
PP    O
is    O
converted    O
to    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
IPP    O
)    O
and    O
dimethylallyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
DMAPP    O
)    O
by    O
HMB    O
-    O
PP    O
reductase    O
(    O
LytB    O
,    O
IspH    O
)    O
.    O

Simplified    O
version    O
of    O
the    O
steroid    O
synthesis    O
pathway    O
with    O
the    O
terpenoid    O
intermediates    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
IPP    O
)    O
,    O
dimethylallyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
DMAPP    O
)    O
,    O
geranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
GPP    O
)    O
,    O
and    O
squalene    O
shown    O
.    O

Isoprene    O
itself    O
does    O
not    O
undergo    O
the    O
building    O
process    O
,    O
but    O
rather    O
activated    O
forms    O
,    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
IPP    O
or    O
also    O
isopentenyl    O
diphosphate    O
)    O
and    O
dimethylallyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
DMAPP    O
or    O
also    O
dimethylallyl    O
diphosphate    O
)    O
,    O
are    O
the    O
components    O
in    O
the    O
biosynthetic    O
pathway    O
.    O

Isopentenyl    O
pyrophosphate    O
isomerase    O
(    O
IPP    O
isomerase    O
)    O
,    O
also    O
known    O
as    O
Isopentenyl    O
-    O
diphosphate    O
delta    O
isomerase    O
,    O
is    O
an    O
isomerase    O
that    O
catalyzes    O
the    O
conversion    O
of    O
the    O
relatively    O
un    O
-    O
reactive    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
IPP    O
)    O
to    O
the    O
more    O
-    O
reactive    O
electrophile    O
dimethylallyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
DMAPP    O
)    O
.    O

Pulegone    B-Terpene115068635

pulegone    B-Terpene115068635

Pulegone    B-Terpene115068635
,    O
the    O
molecule    O
in    O
highest    O
concentration    O
in    O
the    O
pennyroyal    O
plant    O
,    O
causes    O
a    O
variety    O
of    O
ailments    O
in    O
those    O
who    O
ingest    O
it    O
and    O
is    O
what    O
causes    O
the    O
plant    O
to    O
have    O
its    O
peppermint    O
flavor    O
.    O

In    O
the    O
dried    O
crude    O
root    O
,    O
their    O
phenolic    O
aglycones    O
are    O
responsible    O
for    O
the    O
typical    O
odor    O
reminiscent    O
of    O
methyl    O
salicylate    O
or    O
anethole    B-Terpene115068635
.    O

It    O
can    O
also    O
be    O
produced    O
by    O
oxidation    O
of    O
anethole    B-Terpene115068635
,    O
a    O
related    O
fragrance    O
that    O
is    O
found    O
in    O
some    O
alcoholic    O
beverages    O
.    O

It    O
is    O
generally    O
obtained    O
by    O
the    O
oxidation    O
of    O
anethole    B-Terpene115068635
or    O
p    O
-    O
methoxyacetophenone    O
.    O

"    O
Nigella    O
sativa    O
"    O
oil    O
contains    O
linoleic    O
acid    O
,    O
oleic    O
acid    O
,    O
palmitic    O
acid    O
,    O
and    O
trans    O
-    O
anethole    B-Terpene115068635
,    O
among    O
other    O
minor    O
constituents    O
.    O

The    O
ouzo    O
effect    O
occurs    O
when    O
a    O
strongly    O
hydrophobic    O
essential    O
oil    O
such    O
as    O
"trans"-anethole    B-Terpene115068635
is    O
dissolved    O
in    O
a    O
water    O
-    O
miscible    O
solvent    O
,    O
such    O
as    O
ethanol    O
,    O
and    O
the    O
concentration    O
of    O
ethanol    O
is    O
lowered    O
by    O
addition    O
of    O
small    O
amounts    O
of    O
water    O
.    O

The    O
main    O
components    O
of    O
the    O
needle    O
essential    O
oil    O
include    O
terpineol    B-Terpene115068635
(    O
30.2%    O
)    O
,    O
linalool    O
(    O
24.47%    O
)    O
,    O
limonene    O
(    O
17.01%    O
)    O
,    O
anethole    B-Terpene115068635
(    O
14.57%    O
)    O
,    O
caryophyllene    O
(    O
3.14%    O
)    O
and    O
eugenol    B-Terpene115068635
(    O
2.14%    O
)    O
.    O

C1    O
domain    O
(    O
also    O
known    O
as    O
phorbol    O
esters    O
/    O
diacylglycerol    O
binding    O
domain    O
)    O
binds    O
an    O
important    O
secondary    O
messenger    O
diacylglycerol    O
(    O
DAG    O
)    O
,    O
as    O
well    O
as    O
the    O
analogous    O
phorbol    B-Terpene115068635
esters    I-Terpene115068635
.    O

Phorbol    B-Terpene115068635
esters    I-Terpene115068635
(    O
such    O
as    O
PMA    O
)    O
are    O
analogues    O
of    O
DAG    O
and    O
potent    O
tumor    O
promoters    O
that    O
cause    O
a    O
variety    O
of    O
physiological    O
changes    O
when    O
administered    O
to    O
both    O
cells    O
and    O
tissues    O
.    O

Croton    O
oil    O
is    O
the    O
source    O
of    O
the    O
chemical    O
compound    O
phorbol    B-Terpene115068635
.    O

Geranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
GPP    O
)    O
is    O
produced    O
from    O
the    O
reaction    O
of    O
a    O
resonance    O
-    O
stable    O
allylic    O
cation    O
,    O
formed    O
from    O
the    O
loss    O
of    O
the    O
pyrophosphate    O
group    O
from    O
DMAPP    O
,    O
and    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
IPP    O
)    O
,    O
and    O
the    O
subsequent    O
loss    O
of    O
a    O
proton    O
.    O

Phosphosphomevalonate    O
decarboxylase    O
through    O
a    O
concerted    O
decarboxylation    O
reaction    O
affords    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
IPP    O
)    O
.    O

Finally    O
,    O
MEcPP    O
is    O
converted    O
to    O
(    O
"    O
E")-4-hydroxy-3-methyl    O
-    O
but-2-enyl    O
pyrophosphate    O
(    O
HMB    O
-    O
PP    O
)    O
by    O
HMB    O
-    O
PP    O
synthase    O
(    O
GcpE    O
,    O
IspG    O
)    O
,    O
and    O
HMB    O
-    O
PP    O
is    O
converted    O
to    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
IPP    O
)    O
and    O
dimethylallyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
DMAPP    O
)    O
by    O
HMB    O
-    O
PP    O
reductase    O
(    O
LytB    O
,    O
IspH    O
)    O
.    O

Chemical    O
structure    O
of    O
the    O
terpenoid    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
,    O
an    O
intermediate    O
in    O
the    O
HMG    O
-    O
CoA    O
reductase    O
pathway    O
.    O

Simplified    O
version    O
of    O
the    O
steroid    O
synthesis    O
pathway    O
with    O
the    O
terpenoid    O
intermediates    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
IPP    O
)    O
,    O
dimethylallyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
DMAPP    O
)    O
,    O
geranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
GPP    O
)    O
,    O
and    O
squalene    O
shown    O
.    O

Isoprene    O
itself    O
does    O
not    O
undergo    O
the    O
building    O
process    O
,    O
but    O
rather    O
activated    O
forms    O
,    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
IPP    O
or    O
also    O
isopentenyl    O
diphosphate    O
)    O
and    O
dimethylallyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
DMAPP    O
or    O
also    O
dimethylallyl    O
diphosphate    O
)    O
,    O
are    O
the    O
components    O
in    O
the    O
biosynthetic    O
pathway    O
.    O

Of    O
note    O
,    O
all    O
Vγ9/Vδ2    O
T    O
cells    O
recognize    O
the    O
same    O
small    O
microbial    O
compound    O
(    O
"    O
E")-4-hydroxy-3-methyl    O
-    O
but-2-enyl    O
pyrophosphate    O
(    O
HMB    O
-    O
PP    O
)    O
,    O
a    O
natural    O
intermediate    O
of    O
the    O
non    O
-    O
mevalonate    O
pathway    O
of    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
IPP    O
)    O
biosynthesis    O
.    O

IPP    B-Terpene115068635
itself    O
is    O
structurally    O
closely    O
related    O
to    O
HMB    O
-    O
PP    O
and    O
ubiquitously    O
present    O
in    O
all    O
living    O
cells    O
(    O
i.e.    O
also    O
in    O
human    O
cells    O
)    O
,    O
yet    O
its    O
potency    O
"    O
in    O
vitro    O
"    O
is    O
reduced    O
10,000    O
fold    O
;    O
whether    O
IPP    O
represents    O
a    O
physiological    O
'    O
danger    O
'    O
signal    O
of    O
stressed    O
or    O
transformed    O
cells    O
is    O
still    O
unclear    O
.    O

Thus    O
,    O
the    O
presence    O
of    O
a    O
functional    O
Vγ9/Vδ2    O
TCR    O
appears    O
mandatory    O
for    O
a    O
response    O
to    O
non    O
-    O
peptidic    O
antigens    O
although    O
the    O
basis    O
for    O
the    O
huge    O
differences    O
in    O
bioactivity    O
between    O
closely    O
related    O
molecules    O
like    O
HMB    O
-    O
PP    O
and    O
IPP    B-Terpene115068635
can    O
not    O
be    O
explained    O
by    O
conventional    O
epitope    O
presentation    O
/    O
recognition    O
models    O
.    O

Isopentenyl    O
pyrophosphate    O
isomerase    O
(    O
IPP    O
isomerase    O
)    O
,    O
also    O
known    O
as    O
Isopentenyl    O
-    O
diphosphate    O
delta    O
isomerase    O
,    O
is    O
an    O
isomerase    O
that    O
catalyzes    O
the    O
conversion    O
of    O
the    O
relatively    O
un    O
-    O
reactive    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
IPP    O
)    O
to    O
the    O
more    O
-    O
reactive    O
electrophile    O
dimethylallyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
DMAPP    O
)    O
.    O

The    O
salvinorins    O
,    O
including    O
the    O
hallucinogenic    O
compound    O
salvinorin    B-Terpene115068635
A    I-Terpene115068635

Salvinorin    B-Terpene115068635
A    I-Terpene115068635
–    O
also    O
κ-opioid    O
agonist    O
.    O

Some    O
drugs    O
are    O
well    O
known    O
for    O
their    O
laughter    O
-    O
facilitating    O
properties    O
(    O
e.    O
g.    O
ethanol    O
and    O
cannabis    O
)    O
,    O
while    O
the    O
others    O
,    O
like    O
salvinorin    B-Terpene115068635
A    I-Terpene115068635
(    O
the    O
active    O
ingredient    O
of    O
"    O
Salvia    O
divinorum    O
"    O
)    O
,    O
can    O
even    O
induce    O
bursts    O
of    O
uncontrollable    O
laughter    O
.    O

RB-64    O
or    O
22-thiocyanatosalvinorin    O
A    O
is    O
a    O
semi    O
-    O
synthetic    O
salvonorin    B-Terpene115068635
derivative    I-Terpene115068635
and    O
a    O
κ-opioid    O
receptor    O
(    O
KOR    O
)    O
agonist    O
which    O
is    O
used    O
in    O
scientific    O
research    O
.    O

Salvinorin    B-Terpene115068635
A    I-Terpene115068635

Well    O
-    O
known    O
terpenoids    O
include    O
citral    B-Terpene115068635
,    O
menthol    O
,    O
camphor    O
,    O
salvinorin    B-Terpene115068635
A    I-Terpene115068635
in    O
the    O
plant    O
"    O
Salvia    O
divinorum    O
"    O
,    O
the    O
cannabinoid    B-Terpene115068635
found    O
in    O
cannabis    O
,    O
ginkgolide    O
and    O
bilobalide    O
found    O
in    O
"    O
Ginkgo    O
biloba    O
"    O
,    O
and    O
the    O
curcuminoids    O
found    O
in    O
turmeric    O
and    O
mustard    O
seed    O
.    O

Herkinorin    O
is    O
an    O
opioid    O
analgesic    O
that    O
is    O
an    O
analogue    O
of    O
the    O
natural    O
product    O
Salvinorin    B-Terpene115068635
A    I-Terpene115068635
It    O
was    O
discovered    O
in    O
2005    O
during    O
structure    O
-    O
activity    O
relationship    O
studies    O
into    O
neoclerodane    O
diterpenes    O
,    O
the    O
family    O
of    O
chemical    O
compounds    O
of    O
which    O
Salvinorin    O
A    O
is    O
a    O
member    O
.    O

Initial    O
formulations    O
of    O
the    O
herbicide    O
produced    O
toxic    O
levels    O
of    O
other    O
trichothecene    B-Terpene115068635
as    O
byproducts    O
,    O
though    O
the    O
ARS    O
discovered    O
growing    O
"    O
M.    O
verrucaria    O
"    O
in    O
a    O
fermenter    O
on    O
a    O
liquid    O
instead    O
of    O
a    O
solid    O
diet    O
limited    O
or    O
eliminated    O
the    O
problem    O
.    O

The    O
US    O
mycotoxin    O
analyses    O
were    O
reported    O
in    O
the    O
scientific    O
literature    O
in    O
1983    O
and    O
1984    O
and    O
reported    O
small    O
amounts    O
of    O
mycotoxins    O
called    O
trichothecene    B-Terpene115068635
,    O
ranging    O
from    O
the    O
parts    O
per    O
million    O
to    O
traces    O
in    O
the    O
parts    O
per    O
billion    O
range    O
.    O

Trichothecenes    B-Terpene115068635
:    O
The    O
trichothecenes    O
constitute    O
a    O
family    O
of    O
more    O
than    O
sixty    O
sesquiterpenoid    O
metabolites    O
produced    O
by    O
a    O
number    O
of    O
fungal    O
genera    O
,    O
including    O
Fusarium    O
,    O
Myrothecium    O
,    O
Phomopsis    O
,    O
Stachybotrys    O
,    O
Trichoderma    O
,    O
Trichothecium    O
,    O
and    O
others    O
.    O

Trichothecenes    B-Terpene115068635
–    O
sourced    O
from    O
Cephalosporium    O
,    O
Fusarium    O
,    O
Myrothecium    O
,    O
Stachybotrys    O
and    O
Trichoderma    O
.    O

Monoterpenes    O
(    O
~    O
5%    O
)    O
:    O
β-pinene    O
,    O
myrcene    O
,    O
β-phellandrene    O
,    O
"    O
cis    O
"-    O
ocimene    O
,    O
terpinolene    O
,    O
and    O
terpineol    B-Terpene115068635
.    O

Several    O
floral    O
scent    O
compounds    O
of    O
"    O
Monotropastrum    O
humile    O
"    O
,    O
linalool    O
,    O
α-terpineol    B-Terpene115068635
,    O
and    O
geraniol    B-Terpene115068635
,    O
have    O
been    O
demonstrated    O
to    O
be    O
bumble    O
bee    O
attractants    O
.    O

Examples    O
of    O
monoterpenes    O
and    O
monoterpenoids    O
include    O
geraniol    B-Terpene115068635
,    O
terpineol    B-Terpene115068635
(    O
present    O
in    O
lilacs    O
)    O
,    O
limonene    O
(    O
present    O
in    O
citrus    O
fruits    O
)    O
,    O
myrcene    O
(    O
present    O
in    O
hops    O
)    O
,    O
linalool    O
(    O
present    O
in    O
lavender    O
)    O
or    O
pinene    O
(    O
present    O
in    O
pine    O
trees    O
)    O
.    O

While    O
largely    O
indistinguishable    O
in    O
appearance    O
,    O
specimens    O
of    O
"    O
T.    O
vulgaris    O
"    O
may    O
be    O
assigned    O
to    O
one    O
of    O
seven    O
different    O
chemotypes    O
,    O
depending    O
on    O
whether    O
the    O
dominant    O
component    O
of    O
the    O
essential    O
oil    O
is    O
thymol    O
,    O
carvacrol    B-Terpene115068635
,    O
linalool    O
,    O
geraniol    B-Terpene115068635
,    O
sabinene    O
hydrate    O
(    O
thuyanol    O
)    O
,    O
α-terpineol    B-Terpene115068635
,    O
or    O
eucalyptol    B-Terpene115068635
.    O

The    O
main    O
components    O
of    O
the    O
needle    O
essential    O
oil    O
include    O
terpineol    B-Terpene115068635
(    O
30.2%    O
)    O
,    O
linalool    O
(    O
24.47%    O
)    O
,    O
limonene    O
(    O
17.01%    O
)    O
,    O
anethole    B-Terpene115068635
(    O
14.57%    O
)    O
,    O
caryophyllene    O
(    O
3.14%    O
)    O
and    O
eugenol    B-Terpene115068635
(    O
2.14%    O
)    O
.    O

The    O
most    O
active    O
toxin    O
,    O
resiniferatoxin    B-Terpene115068635
,    O
binds    O
to    O
pain    O
receptors    O
in    O
the    O
same    O
way    O
as    O
capsaicin    O
but    O
much    O
more    O
powerfully    O
.    O

The    O
AUA    O
guidelines    O
also    O
listed    O
several    O
discontinued    O
treatments    O
,    O
including    O
long    O
-    O
term    O
oral    O
antibiotics    O
,    O
intravesical    O
bacillus    O
Calmette    O
Guerin    O
,    O
intravesical    O
resiniferatoxin    B-Terpene115068635
)    O
,    O
high    O
-    O
pressure    O
and    O
long    O
-    O
duration    O
hydrodistention    O
,    O
and    O
systemic    O
glucocorticoids    O
.    O

In    O
addition    O
to    O
a    O
variety    O
of    O
irritant    O
phorbol    O
-    O
type    O
esters    O
,    O
the    O
latex    O
contains    O
resiniferatoxin    B-Terpene115068635
and    O
tinyatoxin    B-Terpene115068635
,    O
two    O
closely    O
related    O
highly    O
irritant    O
resiniferonol    O
-    O
type    O
esters    O
.    O

Prenol    B-Terpene115068635

The    O
enzyme    O
is    O
involved    O
in    O
biosynthesis    O
of    O
dolichol    B-Terpene115068635
(    O
a    O
long    O
-    O
chain    O
polyprenol    B-Terpene115068635
)    O
with    O
a    O
saturated    O
alpha    O
-    O
isoprene    O
unit    O
.    O

Cis    O
-    O
prenyltransferases    O
include    O
dehydrodolichol    O
diphosphate    O
synthase    O
(    O
involved    O
in    O
the    O
production    O
of    O
a    O
precursor    O
to    O
dolichol    B-Terpene115068635
)    O
.    O

The    O
apicoplast    O
is    O
also    O
thought    O
to    O
have    O
a    O
role    O
in    O
isoprenoid    B-Terpene115068635
synthesis    O
,    O
which    O
are    O
prosthetic    O
groups    O
on    O
many    O
enzymes    O
and    O
also    O
act    O
as    O
precursors    O
to    O
ubiquinones    O
(    O
involved    O
in    O
electron    O
transport    O
)    O
and    O
dolichol    B-Terpene115068635
(    O
involved    O
in    O
glycoprotein    O
formation    O
)    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
palmitoyl    O
-    O
CoA    O
and    O
dolichol    B-Terpene115068635
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
dolichyl    O
palmitate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
3-sn    O
-    O
phosphatidylcholine    O
and    O
dolichol    B-Terpene115068635
,    O
whereas    O
its    O
two    O
products    O
are    O
1-acyl    O
-    O
sn    O
-    O
glycero-3-phosphocholine    O
and    O
acyldolichol    O
.    O

Iodoresiniferatoxin    B-Terpene115068635

Neomogroside    B-Terpene115068635
is    O
a    O
cucurbitane    O
glycoside    O
isolated    O
from    O
the    O
fruit    O
of    O
"    O
Siraitia    O
grosvenorii    O
"    O
.    O

Big    O
Sagebrush    O
(    O
"    O
Artemisia    O
tridentata    O
"    O
)    O
contains    O
sesquiterpene    B-Terpene115068635
lactones    I-Terpene115068635
which    O
are    O
sesquiterpenoids    O
(    O
built    O
from    O
three    O
isoprene    O
units    O
)    O
and    O
contain    O
a    O
lactone    O
ring    O
,    O
hence    O
the    O
name    O
.    O

Artemisinins    O
are    O
sesquiterpene    B-Terpene115068635
lactone    I-Terpene115068635
isolated    O
from    O
"    O
Artemisia    O
annua    O
"    O
,    O
a    O
Chinese    O
traditional    O
medicine    O
.    O

The    O
genus    O
"    O
Crepis    O
"    O
is    O
a    O
rich    O
source    O
of    O
costus    O
lactone    O
-    O
type    O
guaianolides    O
,    O
a    O
class    O
of    O
sesquiterpene    B-Terpene115068635
lactone    I-Terpene115068635
.    O

Parthenolide    O
is    O
a    O
sesquiterpene    B-Terpene115068635
lactone    I-Terpene115068635
of    O
the    O
germacranolide    O
class    O
which    O
occurs    O
naturally    O
in    O
the    O
plant    O
feverfew    O
(    O
"    O
Tanacetum    O
parthenium    O
"    O
)    O
,    O
after    O
which    O
it    O
is    O
named    O
.    O

Citral    B-Terpene115068635

Additional    O
rearrangements    O
and    O
oxidations    O
provide    O
compounds    O
such    O
as    O
citral    B-Terpene115068635
,    O
citronellal    O
,    O
citronellol    B-Terpene115068635
,    O
linalool    O
,    O
and    O
many    O
others    O
.    O

The    O
oil    O
's    O
main    O
component    O
is    O
citral    B-Terpene115068635
,    O
at    O
70    O
-    O
85%    O
of    O
the    O
oil    O
.    O

Decanal    O
is    O
an    O
important    O
component    O
in    O
citrus    O
,    O
along    O
with    O
octanal    O
,    O
citral    B-Terpene115068635
,    O
and    O
sinensal    O
.    O

Well    O
-    O
known    O
terpenoids    O
include    O
citral    B-Terpene115068635
,    O
menthol    O
,    O
camphor    O
,    O
salvinorin    B-Terpene115068635
A    I-Terpene115068635
in    O
the    O
plant    O
"    O
Salvia    O
divinorum    O
"    O
,    O
the    O
cannabinoid    B-Terpene115068635
found    O
in    O
cannabis    O
,    O
ginkgolide    O
and    O
bilobalide    O
found    O
in    O
"    O
Ginkgo    O
biloba    O
"    O
,    O
and    O
the    O
curcuminoids    O
found    O
in    O
turmeric    O
and    O
mustard    O
seed    O
.    O

He    O
worked    O
with    O
Philippe    O
Barbier    O
on    O
terpene    O
derivatives    O
used    O
in    O
the    O
manufacture    O
of    O
perfumes    O
like    O
citral    B-Terpene115068635
,    O
rhodinal    O
and    O
geraniol    B-Terpene115068635
.    O

perilla    O
sugar    O
-    O
perillartine    B-Terpene115068635
,    O
a    O
sweetener    O

Citronellol    O
is    O
used    O
as    O
a    O
raw    O
material    O
for    O
the    O
production    O
of    O
rose    B-Terpene115068635
oxide    I-Terpene115068635
.    O

Examples    O
of    O
diterpenes    O
and    O
diterpenoids    O
are    O
cafestol    B-Terpene115068635
,    O
kahweol    B-Terpene115068635
,    O
cembrene    O
and    O
taxadiene    O
(    O
precursor    O
of    O
taxol    O
)    O
.    O

It    O
acts    O
as    O
a    O
potent    O
and    O
selective    O
cannabinoid    B-Terpene115068635
receptor    O
agonist    O
,    O
with    O
high    O
potency    O
at    O
both    O
the    O
CB1    O
and    O
CB2    O
receptors    O
,    O
but    O
low    O
penetration    O
of    O
the    O
blood    O
–    O
brain    O
barrier    O
.    O

It    O
has    O
been    O
implicated    O
in    O
addictions    O
to    O
alcohol    O
,    O
cannabinoid    B-Terpene115068635
,    O
cocaine    O
,    O
methylphenidate    O
,    O
nicotine    O
,    O
opioids    O
,    O
phencyclidine    O
,    O
propofol    O
,    O
and    O
substituted    O
amphetamines    O
,    O
among    O
others    O
.    O

As    O
of    O
2008    O
there    O
is    O
no    O
concrete    O
evidence    O
that    O
cannabinoid    B-Terpene115068635
are    O
effective    O
in    O
improving    O
the    O
symptoms    O
of    O
AD    O
or    O
dementia    O
;    O
however    O
,    O
some    O
research    O
looks    O
promising    O
.    O

Many    O
synthetic    O
cannabinoid    B-Terpene115068635
were    O
designed    O
by    O
Pfizer    O
in    O
the    O
1970s    O
and    O
1980s    O
,    O
and    O
feature    O
an    O
alphanumeric    O
code    O
beginning    O
with    O
the    O
prefix    O
"    O
CP    O
"    O
.    O

In    O
certain    O
people    O
,    O
cannabinoids    B-Terpene115068635
may    O
be    O
effective    O
in    O
reducing    O
chemotherapy    O
associated    O
nausea    O
and    O
vomiting    O
.    O

All    O
three    O
demonstrated    O
heavy    O
involvement    O
of    O
the    O
CB1    O
cannabinoid    O
receptor    O
in    O
depolarization    O
-    O
induced    O
suppression    O
of    O
inhibition    O
,    O
suggesting    O
that    O
the    O
endocannabinoids    B-Terpene115068635
were    O
the    O
brain    O
's    O
mediators    O
of    O
depolarization    O
-    O
induced    O
suppression    O
of    O
inhibition    O
.    O

Virodhamine    O
(    O
O    O
"-    O
arachidonoyl    O
ethanolamine    O
;    O
"    O
'    O
O    O
-    O
AEA    O
)    O
is    O
an    O
endocannabinoid    B-Terpene115068635
and    O
a    O
nonclassic    O
eicosanoid    B-Terpene115068635
,    O
derived    O
from    O
arachidonic    O
acid    O
.    O
"    O

Cannabinoid    B-Terpene115068635
:    O
THC    O
(    O
~    O
30%    O
)    O
and    O
THCA    O
(    O
~    O
60%    O
)    O
.    O

Vitaliy    O
Khan    O
of    O
Kazakhstan    O
originally    O
won    O
the    O
gold    O
medal    O
,    O
but    O
was    O
disqualified    O
after    O
he    O
tested    O
positive    O
for    O
Cannabinoid    B-Terpene115068635
.    O

Kazakhstan    O
originally    O
won    O
the    O
gold    O
medal    O
,    O
but    O
was    O
disqualified    O
after    O
Vitaliy    O
Khan    O
tested    O
positive    O
for    O
Cannabinoid    B-Terpene115068635
.    O

Cannabinodiol    O
,    O
a    O
cannabinoid    B-Terpene115068635

Cannabinolic    O
acid    O
,    O
a    O
cannabinoid    B-Terpene115068635

A    O
report    O
prepared    O
for    O
the    O
Australian    O
National    O
Council    O
on    O
Drugs    O
concluded    O
cannabis    O
and    O
other    O
cannabinoid    B-Terpene115068635
are    O
contraindicated    O
in    O
pregnancy    O
as    O
they    O
may    O
interact    O
with    O
the    O
endocannabinoid    O
system    O
.    O

JWH-047    O
is    O
a    O
selective    O
cannabinoid    B-Terpene115068635
ligand    O
,    O
with    O
a    O
bindining    O
affinity    O
of    O
Ki    O
=    O
0.9    O
nM    O
for    O
the    O
CB2    O
subtype    O
,    O
and    O
more    O
than    O
65    O
times    O
selectivity    O
over    O
the    O
CB1    O
.    O

JWH-048    O
is    O
a    O
selective    O
cannabinoid    B-Terpene115068635
ligand    O
,    O
with    O
a    O
bindining    O
affinity    O
of    O
Ki    O
=    O
0.5    O
±    O
0.1    O
nM    O
for    O
the    O
CB2    O
subtype    O
,    O
and    O
more    O
than    O
22    O
times    O
selectivity    O
over    O
the    O
CB1    O
.    O

JWH-057    O
,    O
also    O
known    O
as    O
deoxy-Δ8-THC    O
-    O
DMH    O
,    O
is    O
a    O
selective    O
cannabinoid    B-Terpene115068635
ligand    O
,    O
with    O
a    O
binding    O
affinity    O
of    O
Ki    O
=    O
2.9    O
±    O
1.6    O
nM    O
for    O
the    O
CB2    O
subtype    O
,    O
and    O
Ki    O
=    O
23    O
±    O
7    O
nM    O
for    O
CB1    O
.    O

The    O
discovery    O
of    O
this    O
simplified    O
class    O
of    O
cannabinoid    B-Terpene115068635
derivatives    O
was    O
highly    O
significant    O
in    O
terms    O
of    O
the    O
widespread    O
use    O
of    O
CP    O
55,940    O
for    O
early    O
scientific    O
research    O
into    O
the    O
cannabinoid    O
receptors    O
,    O
as    O
well    O
as    O
later    O
work    O
using    O
more    O
complex    O
compounds    O
such    O
as    O
CP    O
55,244    O
to    O
map    O
the    O
CB1    O
binding    O
site    O
in    O
more    O
detail    O
,    O
but    O
aside    O
from    O
these    O
specific    O
applications    O
,    O
these    O
compounds    O
attracted    O
little    O
attention    O
and    O
no    O
compounds    O
from    O
this    O
series    O
were    O
developed    O
for    O
medical    O
use    O
despite    O
favourable    O
safety    O
profiles    O
in    O
animal    O
studies    O
.    O

However    O
,    O
it    O
is    O
also    O
found    O
that    O
consumption    O
of    O
food    O
for    O
pleasure    O
increased    O
peripheral    O
levels    O
of    O
both    O
ghrelin    O
and    O
the    O
endocannabinoid    B-Terpene115068635
2-arachidonoyl    O
-    O
glycerol    O
(    O
2-AG    O
)    O
in    O
healthy    O
humans    O
,    O
and    O
this    O
hedonic    O
eating    O
influences    O
food    O
intake    O
and    O
,    O
ultimately    O
,    O
body    O
mass    O
.    O

However    O
,    O
phytocannabinoid    B-Terpene115068635
-    O
terpenoid    O
interactions    O
that    O
could    O
produce    O
synergy    O
with    O
respect    O
to    O
treatment    O
of    O
pain    O
,    O
inflammation    O
,    O
depression    O
,    O
anxiety    O
,    O
addiction    O
,    O
epilepsy    O
,    O
cancer    O
,    O
fungal    O
and    O
bacterial    O
infections    O
(    O
including    O
methicillin    O
-    O
resistant    O
"    O
Staphylococcus    O
aureus    O
"    O
)    O
are    O
found    O
.    O

Theresa    O
(    O
Kirsten    O
Dunst    O
)    O
,    O
a    O
woman    O
in    O
the    O
wake    O
of    O
profound    O
loss    O
,    O
is    O
torn    O
between    O
her    O
fractured    O
emotional    O
state    O
and    O
the    O
reality    O
-    O
altering    O
effects    O
of    O
a    O
potent    O
cannabinoid    B-Terpene115068635
drug    O
.    O

Cannabinoids    B-Terpene115068635

Insulin    O
is    O
a    O
major    O
regulator    O
of    O
endocannabinoid    B-Terpene115068635
(    O
EC    O
)    O
metabolism    O
and    O
insulin    O
treatment    O
has    O
been    O
shown    O
to    O
reduce    O
intracellular    O
ECs    O
,    O
the    O
2-arachidonylglycerol    O
(    O
2-AG    O
)    O
and    O
anandamide    O
(    O
AEA    O
)    O
,    O
which    O
correspond    O
with    O
insulin    O
-    O
sensitive    O
expression    O
changes    O
in    O
enzymes    O
of    O
EC    O
metabolism    O
.    O

The    O
tetrahydrocannabinol    O
(    O
THC    O
)    O
and    O
other    O
cannabinoids    B-Terpene115068635
dissolve    O
into    O
the    O
alcohol    O
.    O

Glutamate    O
agonists    O
,    O
cytokine    O
inhibitors    O
,    O
vanilloid    O
-    O
receptor    O
agonists    O
,    O
catecholamine    O
modulators    O
,    O
ion    O
-    O
channel    O
blockers    O
,    O
anticonvulsants    O
,    O
GABA    O
agonists    O
(    O
including    O
opioids    O
and    O
cannabinoids    B-Terpene115068635
)    O
,    O
COX    O
inhibitors    O
,    O
acetylcholine    O
modulators    O
,    O
melatonin    O
analogs    O
(    O
such    O
as    O
Ramelton    O
)    O
,    O
adenosine    O
receptor    O
antagonists    O
and    O
several    O
miscellaneous    O
drugs    O
(    O
including    O
biologics    O
like    O
Passiflora    O
edulis    O
)    O
are    O
being    O
studied    O
for    O
their    O
psychoneuroimmunological    O
effects    O
.    O

The    O
endocannabinoid    B-Terpene115068635
-    O
induced    O
modulation    O
of    O
stress    O
-    O
related    O
behaviors    O
appears    O
to    O
be    O
mediated    O
,    O
at    O
least    O
in    O
part    O
,    O
through    O
the    O
regulation    O
of    O
the    O
serotoninergic    O
system    O
,    O
by    O
which    O
cannabinoid    O
CB1    O
receptors    O
modulate    O
the    O
excitability    O
of    O
dorsal    O
raphe    O
serotonin    O
neurons    O
.    O

Cannabinoids    B-Terpene115068635

Upon    O
addition    O
of    O
the    O
organic    O
solvent    O
,    O
the    O
purple    O
color    O
transfers    O
to    O
the    O
organic    O
layer    O
,    O
indicating    O
that    O
cannabinoids    B-Terpene115068635
may    O
be    O
present    O
.    O

O-2372    O
is    O
an    O
analgesic    O
cannabinoid    B-Terpene115068635
derivative    O
created    O
by    O
Organix    O
Inc.    O
for    O
use    O
in    O
scientific    O
research    O
.    O

cannabinoid    B-Terpene115068635
–    O
drugs    O
that    O
bind    O
to    O
cannabinoid    O
receptors    O

Cannabinoids    B-Terpene115068635

Well    O
-    O
known    O
terpenoids    O
include    O
citral    B-Terpene115068635
,    O
menthol    O
,    O
camphor    O
,    O
salvinorin    B-Terpene115068635
A    I-Terpene115068635
in    O
the    O
plant    O
"    O
Salvia    O
divinorum    O
"    O
,    O
the    O
cannabinoid    B-Terpene115068635
found    O
in    O
cannabis    O
,    O
ginkgolide    O
and    O
bilobalide    O
found    O
in    O
"    O
Ginkgo    O
biloba    O
"    O
,    O
and    O
the    O
curcuminoids    O
found    O
in    O
turmeric    O
and    O
mustard    O
seed    O
.    O

Once    O
leptin    O
has    O
bound    O
to    O
the    O
Ob    O
-    O
Rb    O
receptor    O
,    O
it    O
activates    O
the    O
stat3    O
,    O
which    O
is    O
phosphorylated    O
and    O
travels    O
to    O
the    O
nucleus    O
to    O
effect    O
changes    O
in    O
gene    O
expression    O
,    O
one    O
of    O
the    O
main    O
effects    O
being    O
the    O
down    O
-    O
regulation    O
of    O
the    O
expression    O
of    O
endocannabinoids    B-Terpene115068635
,    O
responsible    O
for    O
increasing    O
hunger    O
.    O

Tinabinol    O
(    O
INN    O
;    O
SP-119    O
)    O
is    O
a    O
synthetic    O
cannabinoid    B-Terpene115068635
drug    O
and    O
analogue    O
of    O
dronabinol    O
which    O
was    O
patented    O
as    O
an    O
antihypertensive    O
but    O
was    O
never    O
marketed    O
.    O

It    O
is    O
found    O
that    O
truffles    O
contain    O
the    O
endocannabinoid    B-Terpene115068635
anandamide    O
(    O
AEA    O
)    O
and    O
the    O
major    O
metabolic    O
enzymes    O
of    O
the    O
endocannabinoid    O
system    O
ECS    O
,    O
and    O
the    O
anandamide    O
content    O
increases    O
in    O
the    O
late    O
stages    O
of    O
truffles’    O
development    O
.    O

Cannabinoid    O
receptor    O
1    O
agonists    O
are    O
a    O
group    O
of    O
euphoriants    O
that    O
includes    O
certain    O
plant-based    B-Terpene115068635
cannabinoids    I-Terpene115068635
(    O
e.g.    O
,    O
THC    O
from    O
the    O
cannabis    O
plant    O
)    O
,    O
endogenous    B-Terpene115068635
cannabinoids    I-Terpene115068635
(    O
e.g.    O
,    O
anandamide    O
)    O
,    O
and    O
synthetic    O
cannabinoids    O
.    O

Medical    O
cannabis    O
or    O
medical    O
marijuana    O
,    O
can    O
refer    O
to    O
the    O
use    O
of    O
cannabis    O
and    O
its    O
cannabinoids    B-Terpene115068635
to    O
treat    O
disease    O
or    O
improve    O
symptoms    O
.    O

Lacosamide    O
does    O
not    O
affect    O
AMPA    O
,    O
kainate    O
,    O
NMDA    O
,    O
GABAA    O
,    O
GABAB    O
or    O
a    O
variety    O
of    O
dopaminergic    O
,    O
serotonergic    O
,    O
adrenergic    O
,    O
muscarinic    O
or    O
cannabinoid    B-Terpene115068635
receptors    O
and    O
does    O
not    O
block    O
potassium    O
or    O
calcium    O
currents    O
.    O

CB-13    O
(    O
CRA13    O
,    O
SAB-378    O
)    O
is    O
a    O
cannabinoid    B-Terpene115068635
drug    O
,    O
which    O
acts    O
as    O
a    O
potent    O
agonist    O
at    O
both    O
the    O
CB1    O
and    O
CB2    O
receptors    O
,    O
but    O
has    O
poor    O
blood–    O

Cannabigerol    O
(    O
CBG    O
)    O
is    O
a    O
non    O
-    O
intoxicating    O
cannabinoid    B-Terpene115068635
found    O
in    O
the    O
"    O
Cannabis    O
"    O
genus    O
of    O
plants    O
,    O
as    O
well    O
as    O
certain    O
other    O
plants    O
including    O
"    O
Helichrysum    O
umbraculigerum    O
"    O
.    O

Cannabinoid    B-Terpene115068635

10.BA    O
Hydrocarbons    O
:    O
05    O
fichtelite    O
,    O
10    O
hartite    O
,    O
15    O
dinite    O
,    O
20    O
idrialite    O
,    O
25    O
kratochvilite    O
,    O
30    O
karpatite    O
,    O
35    O
phylloretine    O
?    O
,    O
40    O
ravatite    O
,    O
45    O
simonellite    B-Terpene115068635
,    O
50    O
evenkite    O

teprenone    B-Terpene115068635
(    O
INN    O
)    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
geranyl    B-Terpene115068635
diphosphate    I-Terpene115068635
(    O
a    O
10    O
carbon    O
precursor    O
)    O
and    O
isopentenyl    B-Terpene115068635
diphosphate    I-Terpene115068635
(    O
a    O
5    O
carbon    O
precursor    O
)    O
whereas    O
its    O
two    O
products    O
are    O
diphosphate    O
and    O
trans    O
,    O
trans    O
-    O
farnesyl    O
diphosphate    O
(    O
a    O
15    O
carbon    O
product    O
)    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
geranyl    B-Terpene115068635
diphosphate    I-Terpene115068635
and    O
isopentenyl    B-Terpene115068635
diphosphate    I-Terpene115068635
,    O
whereas    O
its    O
two    O
products    O
are    O
diphosphate    O
and    O
(    O
2Z,6E)-farnesyl    O
diphosphate    O
.    O

Geranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
GPP    O
)    O
is    O
produced    O
from    O
the    O
reaction    O
of    O
a    O
resonance    O
-    O
stable    O
allylic    O
cation    O
,    O
formed    O
from    O
the    O
loss    O
of    O
the    O
pyrophosphate    O
group    O
from    O
DMAPP    O
,    O
and    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
IPP    O
)    O
,    O
and    O
the    O
subsequent    O
loss    O
of    O
a    O
proton    O
.    O

Geranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
GPP    O
)    O
is    O
the    O
precursor    O
for    O
iridoids    O
.    O

Through    O
a    O
multi    O
-    O
step    O
process    O
,    O
including    O
the    O
dephosphorylation    O
DMAPP    O
,    O
IPP    O
and    O
DMAPP    O
are    O
combined    O
to    O
form    O
the    O
C10    O
compound    O
geranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
GPP    O
)    O
.    O

Synthesis    O
of    O
all    O
higher    O
terpenoids    O
proceeds    O
via    O
formation    O
of    O
geranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
GPP    O
)    O
,    O
farnesyl    O
pyrophosphate    O
(    O
FPP    O
)    O
,    O
and    O
geranylgeranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
GGPP    O
)    O
.    O

Simplified    O
version    O
of    O
the    O
steroid    O
synthesis    O
pathway    O
with    O
the    O
terpenoid    O
intermediates    O
isopentenyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
IPP    O
)    O
,    O
dimethylallyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
DMAPP    O
)    O
,    O
geranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
GPP    O
)    O
,    O
and    O
squalene    O
shown    O
.    O

In    O
higher    O
plants    O
,    O
linalool    O
,    O
as    O
other    O
monoterpenoids    O
,    O
is    O
produced    O
from    O
isopentenyl    O
pyrophosphate    O
via    O
the    O
universal    O
isoprenoid    O
intermediate    O
geranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
,    O
through    O
a    O
class    O
of    O
membrane    O
-    O
bound    O
enzymes    O
named    O
monoterpene    O
synthases    O
.    O

The    O
biosynthesis    O
of    O
CBG    O
begins    O
by    O
loading    O
hexanoyl    O
-    O
CoA    O
onto    O
a    O
polyketide    O
synthase    O
assembly    O
protein    O
and    O
subsequent    O
condensation    O
with    O
three    O
molecules    O
of    O
malonyl    O
-    O
CoA.    O
This    O
polyketide    O
is    O
cyclized    O
to    O
olivetolic    O
acid    O
via    O
olivetolic    O
acid    O
cyclase    O
,    O
and    O
then    O
prenylated    O
with    O
a    O
ten    O
carbon    O
isoprenoid    B-Terpene115068635
precursor    O
,    O
geranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
GPP    O
)    O
,    O
using    O
an    O
aromatic    O
prenyltransferase    O
enzyme    O
,    O
geranyl    O
-    O
pyrophosphate—    O

He    O
developed    O
several    O
such    O
varieties    O
that    O
contained    O
very    O
high    O
levels    O
of    O
gossypol    B-Terpene115068635
(    O
a    O
natural    O
insect    O
toxin    O
)    O
and    O
that    O
manifested    O
physical    O
features    O
(    O
such    O
as    O
glabrous    O
leaf    O
and    O
stem    O
surfaces    O
)    O
that    O
decreased    O
their    O
suitability    O
for    O
insect    O
egg    O
deposition    O
.    O

Delta    O
-    O
cadinene    O
synthase    O
is    O
one    O
of    O
the    O
key    O
steps    O
in    O
the    O
synthesis    O
of    O
gossypol    B-Terpene115068635
,    O
a    O
toxic    O
terpenoid    O
produced    O
in    O
cotton    O
seeds    O
.    O

Determination    O
of    O
the    O
structure    O
of    O
gossypol    B-Terpene115068635
for    O
the    O
cottonseed    O
industry    O
.    O

The    O
plant    O
contains    O
an    O
essential    O
oil    O
(    O
0.5%    O
)    O
which    O
consists    O
of    O
monoterpenoids    O
and    O
sesquiterpenoids    O
:    O
α-pinene    O
,    O
β-pinene    O
,    O
1,4-cineol    B-Terpene115068635
,    O
fenchone    B-Terpene115068635
,    O
α-humulene    O
,    O
β-caryophyllene    O
,    O
trans-β-bergamotene    O
.    O

It    O
is    O
rich    O
in    O
both    O
sulphur    O
compounds    O
and    O
bitter    O
limonoids    B-Terpene115068635
.    O

Limonoid    B-Terpene115068635
such    O
as    O
limonin    B-Terpene115068635
,    O
nomilin    O
,    O
and    O
nomilinic    O
acid    O

More    O
than    O
100    O
chemical    O
constituents    O
have    O
been    O
isolated    O
from    O
the    O
genus    O
"    O
Dictamnus    O
"    O
,    O
including    O
alkaloids    O
,    O
limonoid    B-Terpene115068635
triterpenoid    B-Terpene115068635
,    O
flavonoids    O
,    O
sesquiterpenoids    O
,    O
coumarins    O
,    O
and    O
phenylpropane    O
.    O

Artesunate    B-Terpene115068635
suppositories    I-Terpene115068635
are    O
used    O
for    O
the    O
treatment    O
of    O
malaria    O
.    O

Analysis    O
of    O
several    O
fruits    O
and    O
vegetables    O
showed    O
that    O
phytoene    O
and    O
phytofluene    B-Terpene115068635
are    O
found    O
in    O
majority    O
of    O
fruits    O
and    O
vegetables    O
.    O

Though    O
the    O
idea    O
of    O
a    O
concerted    O
formation    O
of    O
all    O
four    O
rings    O
had    O
been    O
entertained    O
in    O
the    O
past    O
,    O
kinetic    O
studies    O
with    O
(S)-2,3-oxidosqualene    B-Terpene115068635
analogs    O
showed    O
that    O
product    O
formation    O
is    O
achieved    O
through    O
discrete    O
carbocation    O
intermediates    O
(    O
see    O
Figure    O
1    O
)    O
.    O

Because    O
this    O
enzyme    O
catalyzes    O
the    O
formation    O
of    O
precursors    O
far    O
upstream    O
of    O
(S)-2,3-epoxysqualene    B-Terpene115068635
and    O
cholesterol    O
,    O
statins    O
may    O
negatively    O
influence    O
amounts    O
of    O
intermediates    O
required    O
for    O
other    O
biosynthetic    O
pathways    O
(    O
e.g.    O
synthesis    O
of    O
isoprenoids    B-Terpene115068635
,    O
coenzyme    O
Q    O
)    O
.    O

Aconites    O
have    O
been    O
used    O
more    O
recently    O
in    O
murder    O
plots    O
;    O
they    O
contain    O
the    O
chemical    O
alkaloids    O
aconitine    B-Terpene115068635
,    O
mesaconitine    O
,    O
hypaconitine    O
and    O
jesaconitine    O
,    O
which    O
are    O
highly    O
toxic    O
.    O

It    O
combines    O
7    O
drugs    O
:    O
7/10    O
of    O
a    O
bushel    O
of    O
hemp    O
-    O
seeds    O
,    O
7    O
ounces    O
of    O
"    O
Smilax    O
"    O
,    O
6    O
ounces    O
of    O
"    O
Rehmannia    O
glutinosa    O
"    O
,    O
5    O
ounces    O
of    O
aconite    B-Terpene115068635
,    O
5    O
ounces    O
of    O
cloud    O
-    O
shaped    O
agaric    O
mushrooms    O
,    O
4    O
ounces    O
of    O
cinnamon    O
,    O
and    O
a    O
7-inch    O
long    O
"    O
Zanthoxylum    O
"    O
root    O
.    O

Aconitine    B-Terpene115068635

aconitine    B-Terpene115068635

Extracts    O
from    O
plants    O
containing    O
toxic    O
alkaloids    O
,    O
such    O
as    O
aconitine    B-Terpene115068635
and    O
tubocurarine    O
,    O
were    O
used    O
since    O
antiquity    O
for    O
poisoning    O
arrows    O
.    O

Aconitine    B-Terpene115068635
:    O
Raw    O
Fu    O
Zi    O
,    O
0.004%    O
;    O
prepared    O
Fu    O
Zi    O
,    O
trace    O
/    O
none    O
.    O

Juvenile    B-Terpene115068635
hormone    I-Terpene115068635
(    O
JH    O
)    O
controls    O
insect    O
metamorphosis    O
.    O

Juvenile    B-Terpene115068635
hormone    I-Terpene115068635
esterase    O
is    O
induced    O
by    O
factors    O
naturally    O
occurring    O
in    O
the    O
head    O
of    O
insects    O
.    O

In    O
addition    O
,    O
it    O
is    O
induced    O
by    O
treatment    O
of    O
insects    O
with    O
either    O
natural    O
juvenile    B-Terpene115068635
hormone    I-Terpene115068635
,    O
with    O
JH    O
I    O
being    O
the    O
most    O
potent    O
inducer    O
.    O

The    O
role    O
of    O
juvenile    O
hormone    O
binding    O
proteins    O
are    O
also    O
important    O
,    O
as    O
they    O
afford    O
juvenile    B-Terpene115068635
hormone    I-Terpene115068635
protection    O
from    O
hydrolytic    O
enzymes    O
.    O

Injection    O
of    O
an    O
esterase    O
inhibitor    O
,    O
EPPAT    O
,    O
was    O
found    O
to    O
increase    O
juvenile    B-Terpene115068635
hormone    I-Terpene115068635
titers    O
,    O
and    O
starvation    O
was    O
found    O
to    O
increase    O
juvenile    O
hormone    O
titers    O
.    O

They    O
secrete    O
the    O
juvenile    B-Terpene115068635
hormone    I-Terpene115068635
,    O
which    O
regulate    O
reproduction    O
and    O
metamorphosis    O
.    O

Bactoprenol    B-Terpene115068635
is    O
a    O
lipid    O
synthesized    O
by    O
three    O
different    O
species    O
of    O
lactobacilli    O
.    O

DON    B-Terpene115068635
(    O
DeoxyNivalenol    O
)    O

Four    O
trichothecenes    O
,    O
T-2    O
toxin    O
,    O
HT-2    O
toxin    O
,    O
diacetoxyscirpenol    O
(    O
DAS    O
)    O
and    O
deoxynivalenol    B-Terpene115068635
(    O
DON    O
)    O
have    O
been    O
most    O
commonly    O
encountered    O
by    O
humans    O
and    O
animals    O
.    O

The    O
electrons    O
transfer    O
from    O
pheophytin    O
to    O
plastoquinone    B-Terpene115068635
,    O
which    O
takes    O
the    O
2e−    O
from    O
Pheophytin    O
,    O
and    O
two    O
H+    O
atoms    O
from    O
the    O
stroma    O
and    O
forms    O
PQH2    O
,    O
which    O
later    O
is    O
broken    O
into    O
PQ    O
,    O
the    O
2e−    O
is    O
released    O
to    O
Cytochrome    O
b6f    O
complex    O
and    O
the    O
two    O
H+    O
ions    O
are    O
released    O
into    O
thylakoid    O
lumen    O
.    O

In    O
eukaryotes    O
,    O
HPPD    O
is    O
used    O
to    O
regulate    O
blood    O
tyrosine    O
levels    O
,    O
and    O
plants    O
utilize    O
this    O
enzyme    O
to    O
help    O
produce    O
the    O
cofactors    O
plastoquinone    B-Terpene115068635
and    O
tocopherol    O
which    O
are    O
essential    O
for    O
the    O
plant    O
to    O
survive    O
.    O

Strong    O
light    O
causes    O
the    O
reduction    O
of    O
the    O
plastoquinone    B-Terpene115068635
pool    O
,    O
which    O
leads    O
to    O
protonation    O
and    O
double    O
reduction    O
(    O
and    O
double    O
protonation    O
)    O
of    O
the    O
QA    O
electron    O
acceptor    O
of    O
Photosystem    O
II    O
.    O

In    O
plants    O
,    O
dinoseb    O
also    O
inhibits    O
photosynthesis    O
by    O
inhibiting    O
the    O
electron    O
flow    O
from    O
photocomplex    O
II    O
to    O
plastoquinone    B-Terpene115068635
.    O

IPP    O
and    O
DMAPP    O
are    O
the    O
end    O
-    O
products    O
in    O
either    O
pathway    O
,    O
and    O
are    O
the    O
precursors    O
of    O
isoprene    O
,    O
monoterpenoids    O
(    O
10-carbon    O
)    O
,    O
diterpenoids    O
(    O
20-carbon    O
)    O
,    O
carotenoid    B-Terpene115068635
(    O
40-carbon    O
)    O
,    O
chlorophylls    O
,    O
and    O
plastoquinone    B-Terpene115068635
(    O
45-carbon    O
)    O
.    O

Catalpol    O
is    O
an    O
iridoid    B-Terpene115068635
glucoside    O
.    O

Iridoid    B-Terpene115068635

Verbenalin    O
is    O
a    O
chemical    O
compound    O
,    O
classified    O
as    O
an    O
iridoid    B-Terpene115068635
glucoside    O
,    O
that    O
is    O
found    O
in    O
"    O
Verbena    O
officinalis    O
"    O
.    O

Based    O
on    O
its    O
partial    O
structure    O
similarity    O
to    O
iridoid    B-Terpene115068635
class    O
of    O
terprenoids    O
,    O
here    O
,    O
a    O
possible    O
biosynthesis    O
pathway    O
was    O
proposed    O
and    O
outlined    O
in    O
figure    O
2    O
.    O

Aucubin    O
is    O
an    O
iridoid    B-Terpene115068635
glycoside    O
.    O

Iridoids    B-Terpene115068635
derive    O
from    O
monoterpenes    O
.    O

It    O
has    O
been    O
shown    O
that    O
larvae    O
with    O
higher    O
amounts    O
of    O
iridoid    B-Terpene115068635
glycosides    O
have    O
better    O
defense    O
against    O
parasitoids    O
and    O
bacterial    O
pathogens    O
.    O

Parts    O
of    O
the    O
plant    O
contain    O
the    O
iridoid    B-Terpene115068635
glycoside    O
ipolamiide    O
,    O
which    O
inhibits    O
insect    O
predation    O
on    O
the    O
plant    O
.    O

Of    O
these    O
linalool    O
and    O
linalyl    B-Terpene115068635
acetate    I-Terpene115068635
dominate    O
,    O
with    O
moderate    O
levels    O
of    O
lavandulyl    O
acetate    O
,    O
terpinen-4-ol    B-Terpene115068635
and    O
lavandulol    O
.    O

Codinaeopsin    B-Terpene115068635
,    O
efrapeptins    O
,    O
zervamicins    O
,    O
and    O
antiamoebin    O
,    O
are    O
made    O
by    O
fungi    O
.    O

Prostacyclin    O
(    O
also    O
called    O
prostaglandin    O
I2    O
or    O
PGI2    O
)    O
is    O
a    O
prostaglandin    O
member    O
of    O
the    O
eicosanoid    B-Terpene115068635
family    O
of    O
lipid    O
molecules    O
.    O

Since    O
thromboxane    O
(    O
an    O
eicosanoid    B-Terpene115068635
stimulator    O
of    O
platelet    O
aggregation    O
)    O
is    O
also    O
downstream    O
of    O
COX    O
enzymes    O
,    O
one    O
might    O
think    O
that    O
the    O
effect    O
of    O
NSAIDs    O
would    O
act    O
to    O
balance    O
.    O

Thromboxane    O
is    O
a    O
member    O
of    O
the    O
family    O
of    O
lipids    O
known    O
as    O
eicosanoids    B-Terpene115068635
.    O

Virodhamine    O
(    O
O    O
"-    O
arachidonoyl    O
ethanolamine    O
;    O
"    O
'    O
O    O
-    O
AEA    O
)    O
is    O
an    O
endocannabinoid    B-Terpene115068635
and    O
a    O
nonclassic    O
eicosanoid    B-Terpene115068635
,    O
derived    O
from    O
arachidonic    O
acid    O
.    O
"    O

This    O
polyunsaturated    O
fatty    O
acid    O
is    O
metabolized    O
by    O
cyclooxygenases    O
to    O
various    O
prostaglandin    O
,    O
thromboxane    O
,    O
and    O
prostacyclin    O
metabolites    O
in    O
what    O
has    O
been    O
termed    O
the    O
first    O
pathway    O
of    O
eicosanoid    B-Terpene115068635
production    O
;    O
it    O
is    O
also    O
metabolized    O
by    O
various    O
lipoxygenases    O
to    O
hydroxyeicosatetraenoic    O
acids    O
(    O
e.g.    O
5-Hydroxyeicosatetraenoic    O
acid    O
,    O
12-Hydroxyeicosatetraenoic    O
acid    O
,    O
15-hydroxyicosatetraenoic    O
acid    O
)    O
and    O
leukotrienes    O
(    O
e.g.    O
leukotriene    O
B4    O
,    O
leukotriene    O
C4    O
)    O
in    O
what    O
has    O
been    O
termed    O
the    O
second    O
pathway    O
of    O
eicosanoid    O
production    O
.    O

HxA3    O
,    O
HxB3    O
,    O
and    O
their    O
isomers    O
are    O
distinguished    O
from    O
most    O
other    O
eicosanoid    B-Terpene115068635
(    O
i.e.    O
signaling    O
molecules    O
made    O
by    O
oxidation    O
of    O
20-carbon    O
fatty    O
acids    O
)    O
in    O
that    O
they    O
contain    O
both    O
epoxide    O
and    O
hydroxyl    O
residues    O
;    O
they    O
are    O
structurally    O
differentiated    O
in    O
particular    O
from    O
two    O
other    O
classes    O
of    O
arachidonic    O
acid    O
-    O
derived    O
eicosanoids    O
,    O
the    O
leukotrienes    O
and    O
lipoxins    O
,    O
in    O
that    O
they    O
lack    O
conjugated    O
double    O
bonds    O
.    O
HxA4    O
and    O
HxB4    O
are    O
distinguished    O
from    O
HxA3    O
and    O
HxB3    O
by    O
possessing    O
four    O
rather    O
than    O
three    O
double    O
bonds    O
.    O

Fish    O
oils    O
contain    O
the    O
omega-3    O
fatty    O
acids    O
eicosapentaenoic    O
acid    O
(    O
EPA    O
)    O
and    O
docosahexaenoic    O
acid    O
(    O
DHA    O
)    O
,    O
precursors    O
of    O
certain    O
eicosanoid    B-Terpene115068635
that    O
are    O
known    O
to    O
reduce    O
inflammation    O
in    O
the    O
body    O
,    O
and    O
have    O
other    O
health    O
benefits    O
,    O
such    O
as    O
treating    O
hypertriglyceridemia    O
,    O
although    O
claims    O
of    O
preventing    O
heart    O
attacks    O
or    O
strokes    O
have    O
not    O
been    O
supported    O
.    O

Inflammation    O
is    O
produced    O
by    O
eicosanoid    B-Terpene115068635
and    O
cytokines    O
,    O
which    O
are    O
released    O
by    O
injured    O
or    O
infected    O
cells    O
.    O

15-Hydroxyeicosatetraenoic    O
acid    O
(    O
also    O
termed    O
15-HETE    O
,    O
15("S")-HETE    O
,    O
and    O
15"S    O
"-    O
HETE    O
)    O
is    O
an    O
eicosanoid    B-Terpene115068635
,    O
i.e.    O
a    O
metabolite    O
of    O
arachidonic    O
acid    O
.    O

both    O
suppresses    O
phospholipase    O
A2    O
,    O
thereby    O
blocking    O
eicosanoid    B-Terpene115068635
production    O
,    O
and    O
inhibits    O
various    O
leukocyte    O
inflammatory    O
events    O
(    O
epithelial    O
adhesion    O
,    O
emigration    O
,    O
chemotaxis    O
,    O
phagocytosis    O
,    O
respiratory    O
burst    O
,    O
etc    O
.    O
)    O
.    O

This    O
occurs    O
by    O
altering    O
the    O
metabolic    O
flux    O
of    O
platelet    O
's    O
eicosanoid    B-Terpene115068635
synthesis    O
pathway    O
,    O
which    O
involves    O
enzymes    O
phospholipase    O
A2    O
,    O
cyclo    O
-    O
oxygenase    O
1    O
,    O
and    O
thromboxane    O
-    O
A    O
synthase    O
.    O

Szczeklik    O
's    O
main    O
research    O
interest    O
included    O
:    O
cardiopulmonary    O
diseases    O
,    O
aspirin    O
-    O
induced    O
asthma    O
,    O
chemical    O
mediators    O
in    O
diseases    O
of    O
circulatory    O
and    O
respiratory    O
systems    O
with    O
special    O
reference    O
to    O
eicosanoid    B-Terpene115068635
.    O

The    O
resulting    O
substances    O
,    O
called    O
"    O
eicosanoid    B-Terpene115068635
"    O
:    O
prostaglandins    O
(    O
PG    O
)    O
,    O
leukotrienes    O
(    O
LT    O
)    O
,    O
lipoxins    O
and    O
thromboxane    O
(    O
TX    O
)    O
;    O
and    O
docosanoids    O
:    O
resolvins    O
,    O
protectins    O
,    O
and    O
maresins    O
,    O
are    O
powerful    O
lipid    O
mediators    O
that    O
produce    O
specific    O
actions    O
in    O
the    O
organism    O
;    O
they    O
organize    O
inflammation    O
,    O
hemodynamic    O
,    O
immune    O
response    O
and    O
the    O
repair    O
of    O
tissue    O
.    O

Ganoderic    B-Terpene115068635
acids    I-Terpene115068635
are    O
a    O
class    O
of    O
closely    O
related    O
triterpenoid    B-Terpene115068635
(    O
derivatives    O
from    O
lanosterol    O
)    O
found    O
in    O
"    O
Ganoderma    O
"    O
mushrooms    O
.    O

The    O
ryanodine    O
receptors    O
are    O
named    O
after    O
the    O
plant    O
alkaloid    O
ryanodine    B-Terpene115068635
,    O
to    O
which    O
they    O
show    O
a    O
high    O
affinity    O
.    O

Ryanodine    B-Terpene115068635
locks    O
the    O
RyRs    O
at    O
half    O
-    O
open    O
state    O
at    O
nanomolar    O
concentrations    O
,    O
yet    O
fully    O
closes    O
them    O
at    O
micromolar    O
concentration    O
.    O

Camphor    O
can    O
also    O
be    O
reduced    O
to    O
isoborneol    B-Terpene115068635
using    O
sodium    O
borohydride    O
.    O

Camphor    O
,    O
borneol    B-Terpene115068635
and    O
eucalyptol    B-Terpene115068635
are    O
examples    O
of    O
bicyclic    O
monoterpenoids    O
containing    O
ketone    O
,    O
alcohol    O
,    O
and    O
ether    O
functional    O
groups    O
,    O
respectively    O
.    O

At    O
least    O
18    O
Microbial    O
VOCs    O
(    O
MVOCs    O
)    O
have    O
been    O
characterised    O
including    O
1-octen-3-ol    O
,    O
3-methylfuran    O
,    O
2-pentanol    O
,    O
2-hexanone    O
,    O
2-heptanone    O
,    O
3-octanone    O
,    O
3-octanol    O
,    O
2-octen-1-ol    O
,    O
1-octene    O
,    O
2-pentanone    O
,    O
2-nonanone    O
,    O
borneol    B-Terpene115068635
,    O
geosmin    O
,    O
1-butanol    O
,    O
3-methyl-1-butanol    O
,    O
3-methyl-2-butanol    O
,    O
and    O
thujopsene    O
.    O

Its    O
ingredients    O
include    O
menthol    O
,    O
paraffin    O
,    O
Vaseline    O
,    O
herbs    O
,    O
borneol    B-Terpene115068635
,    O
camphor    O
,    O
and    O
methyl    O
salicylate    O
.    O

In    O
more    O
detail    O
,    O
they    O
are    O
"    O
spices    O
and    O
fragrances    O
such    O
as    O
Aloeswood    O
(    O
agalloch    O
,    O
Garro    O
/    O
Gharo    O
)    O
,    O
musk    O
,    O
cloves    O
,    O
sandalwood    O
oil    O
,    O
frankincense    O
(    O
or    O
retinite    O
)    O
,    O
birtwarth    O
root    O
,    O
borneol    B-Terpene115068635
,    O
camphor    O
;    O
precious    O
woods    O
such    O
as    O
sandalwood    O
,    O
Sandarswood    O
,    O
Bichofia    O
and    O
sappanwood    O
;    O
medicines    O
such    O
as    O
Alum    O
,    O
elixir    O
of    O
gold    O
,    O
elixir    O
of    O
silver    O
,    O
croton    O
oil    O
,    O
orpiment    O
,    O
myrobalans    O
,    O
betel    O
(    O
areca    O
nuts    O
)    O
;    O
pigments    O
such    O
as    O
Gamboge    O
,    O
indigo    O
,    O
lac    O
,    O
verdigris    O
,    O
azurite    O
,    O
minium    O
,    O
cinebar    O
and    O
ceruse    O
;    O
textiles    O
such    O
as    O
twill    O
,    O
brocade    O
,    O
scarlet    O
raiment    O
,    O
“    O
elephant    O
eye    O
”    O
damask    O
,    O
soft    O
Koryo    O
brocade    O
,    O
Tonkin    O
brocade    O
,    O
silk    O
gauze    O
and    O
crape    O
;    O
other    O
items    O
such    O
as    O
leopard    O
and    O
tiger    O
skins    O
,    O
rattan    O
,    O
teacups    O
,    O
wicker    O
baskets    O
,    O
rhinoceros    O
horns    O
,    O
water    O
buffalo    O
(    O
horn    O
)    O
scepters    O
,    O
agate    O
belts    O
,    O
glass    O
urns    O
,    O
Chinese    O
bamboo    O
,    O
sweet    O
bamboo    O
,    O
and    O
hollow    O
glass    O
balls    O
.    O
"    O
Except    O
for    O
minerals    O
,    O
the    O
other    O
goods    O
generally    O
originated    O
from    O
forests    O
of    O
South    O
and    O
Southeast    O
Asia    O
transported    O
by    O
ship    O
to    O
East    O
Asia    O
;    O
mineral    O
products    O
were    O
,    O
however    O
,    O
from    O
Central    O
Asia    O
.    O

Agelasimines    B-Terpene115068635
are    O
a    O
group    O
of    O
adenine    O
-    O
related    O
bicyclic    O
diterpenoids    B-Terpene115068635
isolated    O
from    O
the    O
orange    O
sponge    O
"    O
Agelas    O
mauritania    O
"    O
.    O

Auraptene    B-Terpene115068635
is    O
a    O
natural    O
bioactive    O
monoterpene    O
coumarin    O
ether    O
.    O

Carnosic    B-Terpene115068635
acid    I-Terpene115068635

Yellow    O
rain    O
was    O
the    O
subject    O
of    O
a    O
1981    O
political    O
incident    O
in    O
which    O
the    O
United    O
States    O
Secretary    O
of    O
State    O
Alexander    O
Haig    O
accused    O
the    O
Soviet    O
Union    O
of    O
supplying    O
T-2    B-Terpene115068635
mycotoxin    I-Terpene115068635
to    O
the    O
Communist    O
states    O
in    O
Vietnam    O
,    O
Laos    O
and    O
Cambodia    O
for    O
use    O
in    O
counterinsurgency    O
warfare    O
.    O

T-2    B-Terpene115068635
mycotoxin    I-Terpene115068635
.    O

T-2    B-Terpene115068635
toxin    I-Terpene115068635

Citronellol    O
can    O
be    O
prepared    O
by    O
hydrogenation    O
of    O
geraniol    B-Terpene115068635
or    O
nerol    B-Terpene115068635
.    O

Nerol    B-Terpene115068635
is    O
a    O
monoterpene    O
found    O
in    O
many    O
essential    O
oils    O
such    O
as    O
lemongrass    O
and    O
hops    O
.    O

The    O
compound    O
responsible    O
for    O
the    O
characteristic    O
aroma    O
was    O
identified    O
as    O
(    O
–)-("S")-citronellal    O
,    O
which    O
is    O
contained    O
in    O
the    O
leaf    O
oil    O
up    O
to    O
80%    O
;    O
minor    O
components    O
include    O
citronellol    B-Terpene115068635
(    O
10%    O
)    O
,    O
nerol    B-Terpene115068635
and    O
limonene    O
.    O

It    O
may    O
,    O
however    O
,    O
be    O
consumed    O
indirectly    O
,    O
in    O
the    O
form    O
of    O
carotenoids    B-Terpene115068635
such    O
as    O
beta    O
carotene    O
,    O
which    O
can    O
be    O
cleaved    O
to    O
form    O
two    O
retinol    O
molecules    O
.    O

xanthophores    O
(    O
yellow    O
)    O
:    O
contain    O
yellow    O
pigments    O
in    O
the    O
forms    O
of    O
carotenoid    B-Terpene115068635

The    O
primary    O
function    O
of    O
pigments    O
in    O
plants    O
is    O
photosynthesis    O
,    O
which    O
uses    O
the    O
green    O
pigment    O
chlorophyll    O
along    O
with    O
several    O
red    O
and    O
yellow    O
pigments    O
including    O
porphyrins    O
,    O
carotenoid    B-Terpene115068635
,    O
anthocyanins    O
and    O
betalains    O
.    O

In    O
contrast    O
to    O
other    O
known    O
anoxygenic    O
phototrophs    O
,    O
these    O
microbes    O
are    O
obligatory    O
aerobes    O
:    O
They    O
metabolize    O
carbon    O
and    O
other    O
organic    O
substrates    O
and    O
use    O
O2-dependent    O
respiration    O
,    O
but    O
they    O
also    O
contain    O
bacteriochlorophyll    O
a    O
,    O
carotenoids    B-Terpene115068635
,    O
as    O
well    O
as    O
photosynthetic    O
reaction    O
centers    O
and    O
light    O
-    O
harvesting    O
complexes    O
.    O

It    O
tests    O
positive    O
for    O
oxidase    O
and    O
catalase    O
,    O
and    O
contains    O
carotenoid    B-Terpene115068635
pigments    O
,    O
possibly    O
to    O
protect    O
against    O
solar    O
radiation    O
.    O

Phenolic    O
and    O
carotenoid    B-Terpene115068635
compounds    O
with    O
antioxidant    O
properties    O
in    O
vegetables    O
have    O
been    O
found    O
to    O
be    O
retained    O
significantly    O
better    O
through    O
steaming    O
than    O
through    O
frying    O
.    O

They    O
additionally    O
contain    O
water    O
-    O
soluble    O
protein    O
-    O
pigment    O
complexes    O
that    O
exploit    O
carotenoid    B-Terpene115068635
such    O
as    O
peridinin    O
to    O
extend    O
their    O
photosynthetic    O
capacity    O
.    O

Secretions    O
of    O
the    O
urpoygial    O
gland    O
of    O
greater    O
flamingos    O
(    O
"    O
Phoenicopterus    O
roseus    O
"    O
)    O
contain    O
carotenoid    B-Terpene115068635
,    O
organic    O
pigments    O
which    O
give    O
flamingos    O
their    O
pink    O
colour    O
.    O

Chromatography    O
,    O
literally    O
"    O
color    O
writing    O
"    O
,    O
was    O
used    O
—    O
and    O
named—    O
in    O
the    O
first    O
decade    O
of    O
the    O
20th    O
century    O
,    O
primarily    O
for    O
the    O
separation    O
of    O
plant    O
pigments    O
such    O
as    O
chlorophyll    O
(    O
which    O
is    O
green    O
)    O
and    O
carotenoid    B-Terpene115068635
(    O
which    O
are    O
orange    O
and    O
yellow    O
)    O
.    O

The    O
red    O
color    O
is    O
due    O
to    O
the    O
presence    O
of    O
carotenoid    B-Terpene115068635
.    O

These    O
photosystems    O
are    O
light    O
-    O
driven    O
redox    O
centers    O
,    O
each    O
consisting    O
of    O
an    O
antenna    O
complex    O
that    O
uses    O
chlorophylls    O
and    O
accessory    O
photosynthetic    O
pigments    O
such    O
as    O
carotenoids    B-Terpene115068635
and    O
phycobiliproteins    O
to    O
harvest    O
light    O
at    O
a    O
variety    O
of    O
wavelengths    O
.    O

It    O
is    O
high    O
in    O
monounsaturated    O
fats    O
and    O
vitamin    O
E.    O
Avocado    O
oil    O
also    O
enhances    O
the    O
absorption    O
of    O
carotenoid    B-Terpene115068635
and    O
other    O
nutrients    O
.    O

Hematochrome    O
is    O
a    O
mixture    O
of    O
carotenoid    B-Terpene115068635
pigments    O
and    O
their    O
derivates    O
.    O

SbCl3    O
is    O
a    O
reagent    O
for    O
detecting    O
vitamin    O
A    O
and    O
related    O
carotenoid    B-Terpene115068635
in    O
the    O
Carr    O
-    O
Price    O
test    O
.    O

Curing    O
and    O
subsequent    O
aging    O
allow    O
for    O
the    O
slow    O
oxidation    O
and    O
degradation    O
of    O
carotenoids    B-Terpene115068635
in    O
the    O
tobacco    O
leaf    O
.    O

The    O
DU    O
spectrophotometer    O
could    O
be    O
used    O
to    O
study    O
both    O
vitamin    O
A    O
and    O
its    O
precursor    O
carotenoids    B-Terpene115068635
,    O
and    O
rapidly    O
became    O
the    O
preferred    O
method    O
of    O
spectrophotometric    O
analysis    O
.    O

Chlorophylls    O
and    O
carotenoids    B-Terpene115068635
are    O
important    O
in    O
light    O
-    O
harvesting    O
complexes    O
present    O
in    O
plants    O
.    O

He    O
used    O
liquid    O
-    O
adsorption    O
column    O
chromatography    O
with    O
calcium    O
carbonate    O
as    O
adsorbent    O
and    O
petrol    O
ether    O
/    O
ethanol    O
mixtures    O
as    O
eluent    O
to    O
separate    O
chlorophylls    O
and    O
carotenoid    B-Terpene115068635
.    O

With    O
its    O
bitter    O
taste    O
,    O
hay    O
-    O
like    O
fragrance    O
,    O
and    O
slight    O
metallic    O
notes    O
,    O
the    O
apocarotenoid    B-Terpene115068635
-    O
rich    O
saffron    O
has    O
been    O
used    O
as    O
a    O
seasoning    O
,    O
fragrance    O
,    O
dye    O
,    O
and    O
medicine    O
.    O

The    O
different    O
colors    O
on    O
the    O
lip    O
are    O
obtained    O
through    O
a    O
different    O
expression    O
of    O
both    O
anthocyanins    O
and    O
carotenoid    B-Terpene115068635
.    O

The    O
activated    O
terpene    O
geranylgeranyl    O
pyrophosphate    O
is    O
combined    O
with    O
itself    O
to    O
produce    O
the    O
common    O
carotenoid    B-Terpene115068635
precursor    O
,    O
lycopene    O
.    O

Phaseic    O
acid    O
is    O
a    O
product    O
of    O
abscisic    O
acid    O
,    O
which    O
is    O
itself    O
the    O
product    O
of    O
the    O
C40    O
carotenoid    B-Terpene115068635
zeaxanthin    O
via    O
at    O
least    O
four    O
enzymatic    O
steps    O
.    O

The    O
differences    O
are    O
in    O
color    O
(    O
raw    O
palm    O
kernel    O
oil    O
lacks    O
carotenoids    B-Terpene115068635
and    O
is    O
not    O
red    O
)    O
,    O
and    O
in    O
saturated    O
fat    O
content    O
:    O
palm    O
mesocarp    O
oil    O
is    O
49%    O
saturated    O
,    O
while    O
palm    O
kernel    O
oil    O
and    O
coconut    O
oil    O
are    O
81%    O
and    O
86%    O
saturated    O
fats    O
,    O
respectively    O
.    O

The    O
pink    O
or    O
reddish    O
color    O
of    O
flamingos    O
comes    O
from    O
carotenoids    B-Terpene115068635
in    O
their    O
diet    O
of    O
animal    O
and    O
plant    O
plankton    O
.    O

Avocados    O
also    O
contain    O
phytosterols    O
and    O
carotenoids    B-Terpene115068635
,    O
such    O
as    O
lutein    O
and    O
zeaxanthin    O
.    O

During    O
digestion    O
,    O
the    O
plankton    O
is    O
quickly    O
converted    O
to    O
an    O
oily    O
orange    O
liquid    O
that    O
owes    O
its    O
colour    O
to    O
carotenoid    B-Terpene115068635
.    O

At    O
that    O
time    O
,    O
crocetin    O
,    O
a    O
naturally    O
occurring    O
carotenoid    B-Terpene115068635
compound    O
,    O
was    O
the    O
focus    O
of    O
their    O
research    O
.    O

Numerous    O
studies    O
have    O
revealed    O
the    O
presence    O
of    O
phenols    O
,    O
flavonoids    O
,    O
alkaloids    O
,    O
glycosides    O
,    O
phytosterols    O
,    O
carotenoid    B-Terpene115068635
,    O
tannins    O
,    O
fixed    O
oils    O
and    O
fats    O
form    O
different    O
parts    O
of    O
"    O
H.isora    O
"    O
,    O
in    O
varying    O
concentrations    O
.    O

The    O
company    O
owns    O
patent    O
on    O
a    O
device    O
developed    O
by    O
Pharmanex    O
called    O
a    O
"    O
BioPhotonic    O
Scanner    O
"    O
,    O
which    O
is    O
designed    O
to    O
measure    O
the    O
carotenoid    B-Terpene115068635
level    O
in    O
skin    O
.    O

Tetraterpenoid    B-Terpene115068635
(    O
carotenoids    O
)    O
are    O
tetraterpenes    O
that    O
have    O
been    O
modified    O
by    O
chemical    O
transformations    O
such    O
as    O
oxidation    O
or    O
cyclization    O
.    O

Carotenes    O
and    O
carotenoid    B-Terpene115068635
,    O
such    O
as    O
the    O
acyclic    O
lycopene    O
,    O
the    O
monocyclic    O
γ-carotene    O
,    O
and    O
the    O
bicyclic    O
α-    O
and    O
β-carotenes    O

The    O
carotenoid    B-Terpene115068635
lycopene    O
has    O
the    O
psi    O
-    O
end    O
group    O
at    O
both    O
ends    O
.    O

Instead    O
,    O
the    O
colour    O
of    O
the    O
skin    O
is    O
largely    O
due    O
to    O
chromatophores    O
in    O
the    O
dermis    O
,    O
which    O
,    O
in    O
addition    O
to    O
melanin    O
,    O
may    O
contain    O
guanine    O
or    O
carotenoid    B-Terpene115068635
pigments    O
.    O

Some    O
species    O
of    O
aphids    O
have    O
acquired    O
the    O
ability    O
to    O
synthesise    O
red    O
carotenoid    B-Terpene115068635
by    O
horizontal    O
gene    O
transfer    O
from    O
fungi    O
.    O

Modifying    O
the    O
atmosphere    O
inside    O
fresh    O
produce    O
packaging    O
to    O
provide    O
lowered    O
levels    O
of    O
and    O
elevated    O
levels    O
of    O
is    O
beneficial    O
for    O
many    O
fresh    O
produce    O
items    O
and    O
“    O
can    O
reduce    O
respiration    O
,    O
decrease    O
ethylene    O
production    O
and    O
action    O
,    O
retard    O
tissue    O
ripening    O
and    O
softening    O
,    O
retard    O
chlorophyll    O
degradation    O
and    O
biosynthesis    O
of    O
carotenoids    B-Terpene115068635
and    O
anthocyanins    O
,    O
reduce    O
enzymatic    O
browning    O
,    O
alleviate    O
physiological    O
disorders    O
and    O
chilling    O
injury    O
,    O
retard    O
development    O
of    O
decay    O
,    O
and    O
maintain    O
nutritional    O
quality    O
of    O
produce    O
.    O

Geranyltranstransferases    O
are    O
an    O
evolutionarily    O
conserved    O
class    O
of    O
enzymes    O
in    O
Archaea    O
,    O
Bacteria    O
,    O
and    O
Eukarya    O
that    O
participate    O
in    O
a    O
broad    O
range    O
of    O
biosynthetic    O
pathways    O
including    O
those    O
of    O
cholesterol    O
,    O
porphyrin    O
,    O
carotenoids    B-Terpene115068635
,    O
ubiquinone    O
,    O
and    O
isoprenoids    B-Terpene115068635
.    O

It    O
is    O
believed    O
that    O
safranal    O
is    O
a    O
degradation    O
product    O
of    O
the    O
carotenoid    B-Terpene115068635
zeaxanthin    O
via    O
the    O
intermediacy    O
of    O
picrocrocin    O
.    O

Picrocrocin    O
is    O
a    O
degradation    O
product    O
of    O
the    O
carotenoid    B-Terpene115068635
zeaxanthin    O
.    O

Apocarotenal    O
,    O
or    O
"    O
trans"-β-apo-8'-carotenal    O
,    O
is    O
a    O
carotenoid    B-Terpene115068635
found    O
in    O
spinach    O
and    O
citrus    O
fruits    O
.    O

The    O
flame    O
scallop    O
's    O
vibrant    O
red    O
color    O
is    O
due    O
to    O
the    O
large    O
amount    O
of    O
carotenoid    B-Terpene115068635
found    O
within    O
their    O
body    O
.    O

It    O
is    O
colored    O
as    O
a    O
result    O
of    O
concentrating    O
carotenoid    B-Terpene115068635
(    O
including    O
lutein    O
)    O
from    O
the    O
diet    O
and    O
secretes    O
a    O
moderate    O
amount    O
of    O
estrogen    O
to    O
inhibit    O
further    O
release    O
of    O
gonadotropin    O
-    O
releasing    O
hormone    O
(    O
GnRH    O
)    O
and    O
thus    O
secretion    O
of    O
luteinizing    O
hormone    O
(    O
LH    O
)    O
and    O
follicle    O
-    O
stimulating    O
hormone    O
(    O
FSH    O
)    O
.    O

The    O
yellow    O
color    O
and    O
name    O
of    O
the    O
corpus    O
luteum    O
,    O
like    O
that    O
of    O
the    O
macula    O
lutea    O
of    O
the    O
retina    O
,    O
is    O
due    O
to    O
its    O
concentration    O
of    O
certain    O
carotenoid    B-Terpene115068635
,    O
especially    O
lutein    O
.    O

Tetraterpenoid    B-Terpene115068635
,    O
8    O
isoprene    O
units    O
(    O
40C    O
)    O
(    O
e.g.    O
carotenoid    B-Terpene115068635
)    O

IPP    O
and    O
DMAPP    O
are    O
the    O
end    O
-    O
products    O
in    O
either    O
pathway    O
,    O
and    O
are    O
the    O
precursors    O
of    O
isoprene    O
,    O
monoterpenoids    O
(    O
10-carbon    O
)    O
,    O
diterpenoids    O
(    O
20-carbon    O
)    O
,    O
carotenoid    B-Terpene115068635
(    O
40-carbon    O
)    O
,    O
chlorophylls    O
,    O
and    O
plastoquinone    B-Terpene115068635
(    O
45-carbon    O
)    O
.    O

Due    O
to    O
excess    O
exposure    O
to    O
sunlight    O
(    O
and    O
,    O
possibly    O
,    O
a    O
low    O
-    O
carotenoid    B-Terpene115068635
diet    O
)    O
,    O
they    O
often    O
appear    O
rather    O
turquoise    O
(    O
instead    O
of    O
green    O
)    O
in    O
captivity    O
.    O

"    O
O.    O
tauri    O
"    O
was    O
immediately    O
placed    O
in    O
the    O
class    O
Prasinophyceae    O
based    O
on    O
the    O
presence    O
of    O
characteristic    O
chlorophyll    O
pigments    O
and    O
Chlorophyceae    O
-    O
related    O
carotenoids    B-Terpene115068635
,    O
and    O
this    O
classification    O
was    O
confirmed    O
by    O
further    O
work    O
.    O

carotenoid    B-Terpene115068635
pigments    O
)    O
.    O

The    O
color    O
of    O
a    O
bird    O
's    O
beak    O
results    O
from    O
concentrations    O
of    O
pigments    O
—    O
primarily    O
melanins    O
and    O
carotenoids    B-Terpene115068635
—    O
in    O
the    O
epidermal    O
layers    O
,    O
including    O
the    O
rhamphotheca    O
.    O

Individual    O
fruits    O
weigh    O
between    O
270    O
and    O
480    O
mg    O
and    O
contain    O
high    O
amounts    O
of    O
vitamin    O
C    O
,    O
vitamin    O
E    O
,    O
carotenoid    B-Terpene115068635
,    O
flavonoids    O
and    O
health    O
-    O
beneficial    O
fatty    O
acids    O
,    O
as    O
well    O
as    O
higher    O
amounts    O
of    O
vitamin    O
B12    O
than    O
other    O
fruits    O
.    O

Additionally    O
,    O
fruits    O
have    O
high    O
concentrations    O
of    O
carotenoids    B-Terpene115068635
,    O
vitamin    O
E    O
and    O
vitamin    B-Terpene115068635
K    I-Terpene115068635

Source    O
of    O
colouration    O
comes    O
from    O
different    O
pigments    O
within    O
the    O
lizard    O
,    O
with    O
yellow    O
colouration    O
originating    O
from    O
carotenoid    B-Terpene115068635
,    O
and    O
the    O
expression    O
of    O
red    O
/    O
orange    O
colour    O
from    O
pteridines    O
.    O

Aasen´s    O
research    O
areas    O
include    O
determination    O
of    O
the    O
absolute    O
configurations    O
of    O
racemic    O
drugs    O
,    O
isolation    O
,    O
structural    O
determination    O
and    O
syntheses    O
of    O
natural    O
products    O
,    O
"    O
e.g.    O
"    O
carotenoids    B-Terpene115068635
and    O
pyrrolizidine    O
alkaloids    O
,    O
mass    O
spectrometry    O
of    O
specifically    O
deuterium    O
-    O
labelled    O
wax    O
esters    O
,    O
fatty    O
acids    O
and    O
triglycerides    O
,    O
and    O
identification    O
and    O
syntheses    O
of    O
flavour    O
constituents    O
from    O
tobacco    O
and    O
other    O
plants    O
.    O

Carotenoid    B-Terpene115068635
–    O
They    O
are    O
organic    O
pigments    O
that    O
are    O
found    O
in    O
the    O
chloroplasts    O
and    O
chromoplasts    O
of    O
plants    O
and    O
some    O
other    O
photosynthetic    O
organisms    O
,    O
including    O
some    O
bacteria    O
and    O
some    O
fungi    O
.    O

However    O
,    O
in    O
combination    O
with    O
other    O
lipids    O
and    O
carotenoids    B-Terpene115068635
/    O
chlorophylls    O
of    O
thylakoid    O
membranes    O
,    O
they    O
too    O
conform    O
together    O
as    O
lipid    O
bilayers    O
.    O

Unrefined    O
palm    O
oil    O
is    O
a    O
significant    O
source    O
of    O
tocotrienol    B-Terpene115068635
,    O
part    O
of    O
the    O
vitamin    O
E    O
family    O
.    O

β-Tocotrienol    O
is    O
a    O
tocotrienol    B-Terpene115068635
,    O
a    O
member    O
of    O
vitamin    O
E    O
family    O
.    O

Tocotrienol    B-Terpene115068635

Humans    O
require    O
thirteen    O
vitamins    O
in    O
their    O
diet    O
,    O
most    O
of    O
which    O
are    O
actually    O
groups    O
of    O
related    O
molecules    O
(    O
e.g.    O
vitamin    O
E    O
includes    O
tocopherols    O
and    O
tocotrienol    B-Terpene115068635
)    O
.    O

Chemically    O
,    O
phytoecdysteroids    O
are    O
classed    O
as    O
triterpenoid    B-Terpene115068635
,    O
the    O
group    O
of    O
compounds    O
that    O
includes    O
triterpene    O
saponins    O
,    O
phytosterols    O
,    O
and    O
phytoecdysteroids    O
.    O

They    O
often    O
contain    O
β-orcinol    O
depsidones    O
(    O
secondary    O
metabolites    O
of    O
lichens    O
)    O
such    O
as    O
norstictic    O
acid    O
and    O
stictic    O
acids    O
;    O
others    O
have    O
fatty    O
acids    O
or    O
triterpenes    B-Terpene115068635
.    O

Research    O
in    O
Spain    O
has    O
indicated    O
the    O
presence    O
of    O
a    O
triterpene    B-Terpene115068635
,    O
alnulin    O
,    O
renders    O
the    O
tree    O
bark    O
less    O
attractive    O
to    O
the    O
beetle    O
than    O
the    O
Field    O
elm    O
.    O

Material    O
from    O
this    O
species    O
has    O
been    O
analysed    O
,    O
resulting    O
in    O
the    O
identification    O
of    O
six    O
triterpene    B-Terpene115068635
,    O
one    O
diterpene    O
glycoside    O
ester    O
,    O
six    O
steroids    O
,    O
one    O
flavonoid    O
known    O
as    O
cirsilol    O
,    O
and    O
six    O
cinnamic    O
acids    O
derivatives    O
.    O

Caterpillar    O
do    O
not    O
feed    O
on    O
"    O
Momordica    O
charantia    O
"    O
due    O
to    O
presence    O
of    O
the    O
triterpenoid    B-Terpene115068635
glucoside    O
called    O
Momordicine    O
II    O
,    O
which    O
is    O
a    O
natural    O
inhibitor    O
of    O
caterpillar    O
actions    O
.    O

The    O
amyrins    O
are    O
three    O
closely    O
related    O
natural    O
chemical    O
compounds    O
of    O
the    O
triterpene    B-Terpene115068635
class    O
.    O

"    O
Agrimonia    O
pilosa    O
"    O
contains    O
certain    O
chemical    O
components    O
such    O
as    O
agrimonolide    O
,    O
coumarin    O
,    O
tannins    O
,    O
as    O
well    O
as    O
flavonoids    O
,    O
phenylpropanoids    O
,    O
and    O
triterpene    B-Terpene115068635
.    O

Triterpene    B-Terpene115068635

Paraffins    O
occur    O
in    O
leaves    O
of    O
peas    O
and    O
cabbages    O
,    O
alkyl    O
esters    O
in    O
leaves    O
of    O
carnauba    O
palm    O
and    O
banana    O
,    O
the    O
asymmetrical    O
secondary    O
alcohol    O
10-nonacosanol    O
in    O
most    O
gymnosperms    O
such    O
as    O
"    O
Ginkgo    O
biloba    O
"    O
and    O
Sitka    O
spruce    O
,    O
many    O
of    O
the    O
Ranunculaceae    O
,    O
Papaveraceae    O
and    O
Rosaceae    O
and    O
some    O
mosses    O
,    O
symmetrical    O
secondary    O
alcohols    O
in    O
Brassicaceae    O
including    O
"    O
Arabidopsis    O
thaliana    O
"    O
,    O
primary    O
alcohols    O
(    O
mostly    O
octacosan-1-ol    O
)    O
in    O
most    O
grasses    O
Poaceae    O
,    O
"    O
Eucalyptus    O
"    O
and    O
legumes    O
among    O
many    O
other    O
plant    O
groups    O
,    O
β-diketones    O
in    O
many    O
grasses    O
,    O
"    O
Eucalyptus    O
"    O
,    O
box    O
"    O
Buxus    O
"    O
and    O
the    O
Ericaceae    O
,    O
aldehydes    O
in    O
young    O
beech    O
leaves    O
,    O
sugarcane    O
culms    O
and    O
lemon    O
fruit    O
and    O
triterpene    B-Terpene115068635
in    O
fruit    O
waxes    O
of    O
apple    O
,    O
plum    O
and    O
grape    O
Aromatic    O
compounds    O
have    O
been    O
recorded    O
in    O
epicuticular    O
waxes    O
but    O
are    O
generally    O
minor    O
constituents    O
.    O

"    O
Adenophora    O
triphylla    O
"    O
roots    O
contain    O
chemical    O
compounds    O
that    O
are    O
saponins    O
and    O
triterpene    B-Terpene115068635
.    O

The    O
dried    O
roots    O
contain    O
significant    O
amounts    O
of    O
triterpene    B-Terpene115068635
saponins    O
,    O
such    O
as    O
primula    O
acid    O
I    O
/    O
II    O
,    O
while    O
in    O
the    O
flower    O
these    O
constituents    O
are    O
located    O
in    O
the    O
sepals    O
,    O
and    O
the    O
dominating    O
constituents    O
are    O
flavonoids    O
.    O

"    O
Centella    O
"    O
has    O
large    O
amounts    O
of    O
pentacyclic    O
triterpenoid    B-Terpene115068635
including    O
asiaticoside    O
,    O
brahmoside    O
,    O
asiatic    O
acid    O
,    O
and    O
brahmic    O
acid    O
(    O
madecassic    O
acid    O
)    O
.    O

The    O
triterpene    B-Terpene115068635
compounds    O
of    O
"    O
Centella    O
asiatica    O
"    O
.    O

The    O
species    O
is    O
notable    O
for    O
its    O
ability    O
to    O
produce    O
high    O
amounts    O
of    O
hydrocarbons    O
,    O
especially    O
oils    O
in    O
the    O
form    O
of    O
Triterpenes    B-Terpene115068635
,    O
that    O
are    O
typically    O
around    O
30–40%    O
of    O
their    O
dry    O
weight    O
.    O

While    O
"    O
Botryococcus    O
"    O
oils    O
are    O
oils    O
of    O
vegetable    O
origin    O
,    O
they    O
are    O
inedible    O
and    O
chemically    O
very    O
different    O
,    O
being    O
triterpenes    B-Terpene115068635
,    O
and    O
lack    O
the    O
free    O
oxygen    O
atom    O
needed    O
for    O
transesterification    O
.    O

Botryococcenes    O
are    O
unbranched    O
isoprenoid    B-Terpene115068635
triterpenes    B-Terpene115068635
having    O
the    O
formula    O
C"n"H2"n"-10    O
.    O

Triterpenoid    B-Terpene115068635
,    O
6    O
isoprene    O
units    O
(    O
30C    O
)    O
(    O
e.g.    O
sterols    O
)    O

As    O
chains    O
of    O
isoprene    O
units    O
accumulate    O
,    O
the    O
resulting    O
terpenes    O
are    O
classified    O
sequentially    O
by    O
size    O
as    O
hemiterpenes    O
,    O
monoterpenes    O
,    O
sesquiterpenes    O
,    O
diterpenes    O
,    O
sesterterpenes    O
,    O
triterpene    B-Terpene115068635
,    O
and    O
tetraterpenes    O
,    O
all    O
synthesized    O
by    O
terpene    O
synthase    O
.    O

Triterpene    B-Terpene115068635
consist    O
of    O
"    O
six    O
isoprene    O
"    O
units    O
and    O
have    O
the    O
molecular    O
formula    O
C30H48    O
.    O

The    O
plant    O
contains    O
multiple    O
triterpene    B-Terpene115068635
toxins    O
,    O
but    O
the    O
main    O
one    O
is    O
alkaloid    O
phytolaccine    O
.    O

The    O
triterpene    B-Terpene115068635
3α-carboxyacetoxyquercinic    O
acid    O
,    O
3α-carboxyacetoxy-24-methylene-23-oxolanost-8-en-26-oic    O
acid    O
,    O
and    O
5α,8α-epidioxyergosta-6,22-dien-3β-ol    O
(    O
ergosterol    O
peroxide    O
)    O
have    O
been    O
isolated    O
from    O
"    O
D.    O
confragosa    O
"    O
.    O

Among    O
the    O
class    O
of    O
compounds    O
characterized    O
from    O
"    O
S.    O
visco    O
"    O
leaves    O
,    O
the    O
triterpenoid    B-Terpene115068635
lupeol    O
,    O
α-amyrin    O
and    O
β-amyrin    O
may    O
be    O
mainly    O
responsible    O
for    O
the    O
pharmacological    O
activities    O
.    O

More    O
than    O
100    O
chemical    O
constituents    O
have    O
been    O
isolated    O
from    O
the    O
genus    O
"    O
Dictamnus    O
"    O
,    O
including    O
alkaloids    O
,    O
limonoid    B-Terpene115068635
triterpenoid    B-Terpene115068635
,    O
flavonoids    O
,    O
sesquiterpenoids    O
,    O
coumarins    O
,    O
and    O
phenylpropane    O
.    O

The    O
plant    O
contains    O
the    O
oleanane    O
-    O
type    O
triterpenoid    B-Terpene115068635
3beta    O
-    O
acetoxy-11alpha(2',3'-epoxyferulyloxy)-olean-13(18)-ene    O
and    O
α-spinasterol    O
.    O

methyllycaconitine    B-Terpene115068635

Methyllycaconitine    B-Terpene115068635
,    O
a    O
nicotinic    O
acetylcholine    O
receptor    O
antagonist    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
geranylgeranyl    B-Terpene115068635
diphosphate    I-Terpene115068635
and    O
sn-3-O-(geranylgeranyl)glycerol    O
1-phosphate    O
,    O
whereas    O
its    O
two    O
products    O
are    O
diphosphate    O
and    O
2,3-bis    O
-    O
O-(geranylgeranyl)glycerol    O
1-phosphate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
geranylgeranyl    B-Terpene115068635
diphosphate    I-Terpene115068635
and    O
"    O
sn    O
"-    O
glyceryl    O
1-phosphate    O
,    O
whereas    O
its    O
two    O
products    O
are    O
diphosphate    O
and    O
sn-3-O-(geranylgeranyl)glyceryl    O
1-phosphate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
geranylgeranyl    B-Terpene115068635
diphosphate    I-Terpene115068635
and    O
protein    O
-    O
cysteine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S    O
-    O
geranylgeranyl    O
-    O
protein    O
and    O
diphosphate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
geranylgeranyl    B-Terpene115068635
diphosphate    I-Terpene115068635
and    O
protein    O
-    O
cysteine    O
,    O
whereas    O
its    O
two    O
products    O
are    O
S    O
-    O
geranylgeranyl    O
-    O
protein    O
and    O
diphosphate    O
.    O

Synthesis    O
of    O
all    O
higher    O
terpenoids    O
proceeds    O
via    O
formation    O
of    O
geranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
GPP    O
)    O
,    O
farnesyl    O
pyrophosphate    O
(    O
FPP    O
)    O
,    O
and    O
geranylgeranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
GGPP    O
)    O
.    O

They    O
derive    O
from    O
geranylgeranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
.    O

Both    O
isoprenoid    O
chains    O
,    O
geranylgeranyl    B-Terpene115068635
pyrophosphate    I-Terpene115068635
(    O
GGpp    O
)    O
and    O
farnesyl    O
pyrophosphate    O
are    O
products    O
of    O
the    O
HMG    O
-    O
CoA    O
reductase    O
pathway    O
.    O

An    O
example    O
is    O
the    O
ozonolysis    O
of    O
eugenol    B-Terpene115068635
converting    O
the    O
terminal    O
alkene    O
to    O
an    O
aldehyde    O
:    O

Coniferyl    O
alcohol    O
is    O
an    O
intermediate    O
in    O
biosynthesis    O
of    O
eugenol    B-Terpene115068635
and    O
of    O
stilbenoids    O
and    O
coumarin    O
.    O

In    O
Indonesia    O
,    O
a    O
specific    O
type    O
of    O
cigarette    O
that    O
includes    O
cloves    O
called    O
"    O
kretek    O
"    O
was    O
invented    O
in    O
the    O
early    O
1880s    O
as    O
a    O
way    O
of    O
delivering    O
the    O
therapeutic    O
properties    O
of    O
clove    O
oil    O
,    O
or    O
eugenol    B-Terpene115068635
,    O
to    O
the    O
lungs    O
.    O

It    O
contains    O
the    O
chemical    O
eugenol    B-Terpene115068635
,    O
the    O
chemical    O
responsible    O
for    O
the    O
cinnamon    O
aroma    O
in    O
the    O
cinnamon    O
plant    O
.    O

The    O
phenylpropenes    O
,    O
including    O
eugenol    B-Terpene115068635
,    O
chavicol    O
,    O
safrole    O
and    O
estragole    O
,    O
are    O
derived    O
from    O
the    O
monolignols    O
.    O

Eugenol    B-Terpene115068635

The    O
primary    O
chemical    O
constituents    O
of    O
the    O
seed    O
include    O
cinnamaldehyde    O
,    O
gum    O
,    O
tannins    O
,    O
mannitol    O
,    O
coumarins    O
and    O
essential    O
oils    O
(    O
aldehydes    O
,    O
eugenol    B-Terpene115068635
and    O
pinene    O
)    O
.    O

Single    O
synthetic    O
compounds    O
are    O
commonly    O
used    O
as    O
bait    O
to    O
attract    O
and    O
collect    O
males    O
for    O
study    O
,    O
and    O
include    O
many    O
familiar    O
flavorings    O
and    O
odors    O
considered    O
appealing    O
to    O
humans    O
(    O
e.g.    O
,    O
methyl    O
salicylate    O
,    O
eugenol    B-Terpene115068635
,    O
cineole    B-Terpene115068635
,    O
benzyl    O
acetate    O
,    O
methyl    O
benzoate    O
,    O
methyl    O
cinnamate    O
)    O
,    O
and    O
others    O
which    O
are    O
not    O
(    O
e.g.    O
,    O
skatole    O
)    O
.    O

The    O
salts    O
are    O
dissolved    O
in    O
ethanol    O
and    O
mixed    O
with    O
essential    O
oils    O
high    O
in    O
eugenol    B-Terpene115068635
and    O
thymol    O
(    O
such    O
as    O
thyme    O
and    O
clove    O
oils    O
)    O
.    O

The    O
main    O
components    O
of    O
the    O
needle    O
essential    O
oil    O
include    O
terpineol    B-Terpene115068635
(    O
30.2%    O
)    O
,    O
linalool    O
(    O
24.47%    O
)    O
,    O
limonene    O
(    O
17.01%    O
)    O
,    O
anethole    B-Terpene115068635
(    O
14.57%    O
)    O
,    O
caryophyllene    O
(    O
3.14%    O
)    O
and    O
eugenol    B-Terpene115068635
(    O
2.14%    O
)    O
.    O

16-"O    O
"-    O
Methylcafestol    O
,    O
a    O
derivative    O
of    O
cafestol    B-Terpene115068635
,    O
is    O
an    O
isolate    O
of    O
green    O
coffee    O
beans    O
.    O

Examples    O
of    O
diterpenes    O
and    O
diterpenoids    O
are    O
cafestol    B-Terpene115068635
,    O
kahweol    B-Terpene115068635
,    O
cembrene    O
and    O
taxadiene    O
(    O
precursor    O
of    O
taxol    O
)    O
.    O

Carvacrol    B-Terpene115068635

Important    O
terpenoids    O
derived    O
from    O
monocyclic    O
terpenes    O
are    O
menthol    O
,    O
thymol    O
,    O
carvacrol    B-Terpene115068635
and    O
many    O
others    O
.    O

While    O
largely    O
indistinguishable    O
in    O
appearance    O
,    O
specimens    O
of    O
"    O
T.    O
vulgaris    O
"    O
may    O
be    O
assigned    O
to    O
one    O
of    O
seven    O
different    O
chemotypes    O
,    O
depending    O
on    O
whether    O
the    O
dominant    O
component    O
of    O
the    O
essential    O
oil    O
is    O
thymol    O
,    O
carvacrol    B-Terpene115068635
,    O
linalool    O
,    O
geraniol    B-Terpene115068635
,    O
sabinene    O
hydrate    O
(    O
thuyanol    O
)    O
,    O
α-terpineol    B-Terpene115068635
,    O
or    O
eucalyptol    B-Terpene115068635
.    O

The    O
process    O
is    O
actually    O
quite    O
complex    O
,    O
because    O
auxin    O
transported    O
downwards    O
from    O
the    O
lead    O
shoot    O
tip    O
has    O
to    O
interact    O
with    O
several    O
other    O
plant    O
hormones    O
(    O
such    O
as    O
strigolactone    B-Terpene115068635
or    O
cytokinins    O
)    O
in    O
the    O
process    O
on    O
various    O
positions    O
along    O
the    O
growth    O
axis    O
in    O
plant    O
body    O
to    O
achieve    O
this    O
phenomenon    O
.    O

The    O
growth    O
of    O
AM    O
hyphae    O
through    O
the    O
soil    O
is    O
controlled    O
by    O
host    O
root    O
exudates    O
known    O
as    O
strigolactone    B-Terpene115068635
,    O
and    O
the    O
soil    O
phosphorus    O
concentration    O
.    O

Ionone    B-Terpene115068635

Certain    O
materials    O
are    O
ubiquitous    O
in    O
Guerlain    O
’s    O
work    O
:    O
high    O
quality    O
citruses    O
(    O
bergamot    O
,    O
citron    O
,    O
mandarin    O
,    O
sweet    O
and    O
bitter    O
orange    O
)    O
,    O
coumarin    O
,    O
floral    O
absolutes    O
(    O
cassie    O
,    O
jasmine    O
,    O
rose    O
,    O
orange    O
blossom    O
)    O
,    O
green    O
notes    O
(    O
galbanum    O
)    O
,    O
violet    O
-    O
smelling    O
ionones    B-Terpene115068635
and    O
fine    O
qualities    O
of    O
orris    O
,    O
vanilla    O
and    O
ylang    O
-    O
ylang    O
.    O

Ionone    B-Terpene115068635

"    O
Streptomyces    O
bottropensis    O
"    O
can    O
metabolize    O
(    O
+    O
)    O
carvone    B-Terpene115068635
to    O
(    O
+    O
)    O
-bottrospicatol    O
.    O

carvone    B-Terpene115068635

Carvone    B-Terpene115068635
is    O
a    O
member    O
of    O
a    O
family    O
of    O
chemicals    O
called    O
terpenoids    O
.    O

Later    O
the    O
oxidation    O
and    O
reduction    O
reactions    O
of    O
chiral    O
pinene    O
lead    O
also    O
to    O
several    O
possible    O
isomers    O
of    O
carvone    B-Terpene115068635
(    O
the    O
corresponding    O
cyclohexyl    O
ketone    O
dehydrated    O
at    O
the    O
isopropyl    O
)    O
and    O
sobrerol    O
,    O
making    O
it    O
possible    O
to    O
determine    O
reaction    O
mechanism    O
and    O
the    O
structural    O
properties    O
of    O
pinene    O
and    O
of    O
other    O
terpenes    O
.    O

A    O
furanolactone    B-Terpene115068635
is    O
a    O
heterocyclic    O
chemical    O
compound    O
that    O
contains    O
both    O
a    O
lactone    O
and    O
a    O
furan    O
ring    O
structure    O
.    O

Myrcene    O
is    O
converted    O
to    O
myrcenol    B-Terpene115068635
,    O
another    O
fragrance    O
found    O
in    O
lavender    O
,    O
via    O
hydroamination    O
of    O
the    O
1,3-diene    O
by    O
diethylamine    O
followed    O
by    O
hydrolysis    O
and    O
Pd    O
-    O
catalyzed    O
removal    O
of    O
the    O
amine    O
.    O


